| (MCV ) Chemokine-like Protein |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 4000 |
37.0 - 197 fl |
General |
| 1,25-dihydroxyvitamin D (1,25-(OH)2D) |
- |
Human Plasma / Serum |
- |
- |
RIA |
- |
Metabolism |
| 11-dehydro TXB2 |
- |
Human Urine |
- |
- |
ELISA |
45.0 - 3000 pg/mL |
Coagulation |
| 11-desoxycortisol |
- |
Human Plasma / Serum |
- |
- |
RIA |
0.500 - 25.0 ng/mL |
Endocrinology |
| 11b-13,14PGF2 a |
- |
Human Serum |
- |
- |
RIA |
7.80 - 1.00 pg/mL |
Allergy & Immunology |
| 12(s)-hete |
- |
Human Serum / Urine |
- |
- |
ELISA |
200 - 50.000 pg/mL |
Endocrinology |
| 15(s)-hete |
- |
Human Serum / Urine |
- |
- |
ELISA |
80.0 - 20.000 pg/mL |
Endocrinology |
| 17-hydroxyprogesterone |
- |
Human Plasma/Serum/Urine |
- |
- |
RIA |
0.300 - 60.5 nmol/L |
Endocrinology |
| 19-hydroxy prostaglandin E1 |
- |
Human Serum / Urine |
- |
- |
- |
- |
Coagulation |
| 19-nortestosterone |
- |
Human Serum |
- |
- |
ELISA |
0.0200 - 1.00 ng/mL |
Endocrinology |
| 2,5-OAS |
- |
Human Serum |
- |
- |
RIA |
10.0 - 810 pmol/dL |
Allergy & Immunology |
| 25-hydroxy vitamin D |
- |
Human Plasma |
- |
- |
RIA |
4.00 - 400 nM |
Metabolism |
| 3,4-Dihydroxyphenylglycol (DHPG) |
Human |
Plasma |
EDTA |
- |
HPLC |
100 - 5000 pg/ml |
- |
| 3,4-dihydroxyphenylglycol (DHPG) |
- |
Human Plasma |
- |
- |
HPLC |
100 - 5000 pg/mL |
Endocrinology |
| 4-Hydroxyflurbiprofen, 4-hydroxymephenytoin |
Human |
Urine |
None |
- |
LC-MS/MS |
1.00 - 100 µg/ml |
- |
| 5-Fluorouracil |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
5.00 - 5000 ng/ml |
- |
| 5-Fluorouracil |
Rat |
Plasma |
Heparin |
- |
HPLC |
50.0 - 10000 ng/ml |
- |
| 5-Hydroxypiroxicam |
Human |
Urine |
None |
- |
HPLC |
1.00 - 30.0 µg/ml |
- |
| 5-Methyltetrahydrofolic acid |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 400 ng/ml |
- |
| 5-hydroxy-3-indole acetic acid |
- |
Human Urine |
- |
- |
ELISA |
0.200 - 55.0 mg/L |
Endocrinology |
| 6-beta hydroxcortisol |
- |
Human Urine |
- |
- |
LC-MS/MS |
5.00 - 500 ng/mL |
Endocrinology |
| 6b-Hydroxycortisol |
- |
Human Urine |
- |
- |
ELISA |
133 - 2649 pmol/L |
Endocrinology |
| 6b-Hydroxycortisol |
- |
Human Urine |
- |
- |
LC-MS/MS |
5.00 - 500 ng/mL |
Endocrinology |
| ACE activity |
- |
Human Serum |
- |
- |
RIA |
1.42 - 45.3 ACE units |
Metabolism |
| ACTH |
- |
EDTA plasma |
- |
- |
Immulite 2000 |
10 - 1250 pg/mlL |
Diverse |
| ACTH |
- |
Human Plasma |
- |
- |
RIA |
2.20 - 289 pmol/L |
Endocrinology |
| ACTH |
- |
Human Plasma |
- |
- |
IRMA |
5.00 - 1450 pgl/mL |
Endocrinology |
| ADH (vasopressin) |
- |
Human Plasma |
- |
- |
RIA |
1.25 - 80.0 pg/mL |
Endocrinology |
| ADH (vasopressin) |
- |
Human Urine |
- |
- |
RIA |
1.25 - 80.0 pg/mL |
Endocrinology |
| ADP |
- |
Human Plasma |
- |
- |
PAP-4 |
- |
General |
| AFP |
- |
Serum |
- |
- |
ADVIA Centaur |
1.3 - 1000 ng/mL |
Oncology |
| AFP |
- |
Amniotic Fluid |
- |
- |
ADVIA Centaur |
1.08 - 830 IU/mL |
Oncology |
| AFP |
- |
Serum, Heparine Plasma, EDTA Plasma, Amniotic Fluid |
- |
- |
Immulite 2000 |
0.2 - 300 IU/mL, 0.24 - 363 ng/mL |
Oncology |
| ALT |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1100 U/L |
Hepatology |
| ALTP5P |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1000 U/L |
Hepatology |
| ANP |
- |
Human Urine |
- |
- |
ELISA |
320 - 5000 fmol/mL |
Cardiovascular |
| ANP |
- |
Human Plasma |
- |
- |
ELISA |
7.80 - 1000 pg/mL |
Cardiovascular |
| APC res V |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| APC resistance test |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| APTT (activated partial thromboplastin time) |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
General |
| AST |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1000 U/L |
Hepatology |
| ASTP5P |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1000 U/L |
Hepatology |
| Acenocoumarol |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| Acetaminophen |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
66 - 1324 µmol/L |
Drugs of Abuse / Toxicology |
| Acetonide |
- |
Human Serum |
- |
- |
ELISA |
- |
General |
| Acetylcholine Esterase Activity |
- |
Human RBc |
- |
- |
ELISA |
- |
CNS |
| Acetylsalicylic acid / salicylic acid |
Human |
Plasma |
Potassium oxalate |
- |
HPLC |
0.100 - 15.0 / 0.500 - 75.0 µg/ml |
- |
| Acetylsalicylic acid, salicylic acid |
Dog |
Plasma |
Potassium oxalate |
- |
HPLC |
0.500 - 100 µg/ml |
- |
| Acid Folic |
- |
Human Serum |
- |
- |
ELISA |
- |
Haematology |
| Acid Phosphatase |
- |
Serum |
- |
- |
ADVIA 1800 |
4 - 200 µmol/L |
Other General Chemistry |
| Adiponectin |
- |
Human Serum |
- |
- |
ELISA |
3.90 - 250 ng/mL |
Cardiovascular |
| Adrenaline |
Human |
Urine |
None |
- |
HPLC |
2.5-1000 ng/ml |
- |
| Adrenaline |
- |
Human Urine |
- |
- |
HPLC |
2.50 - 1000 ng/mL |
Cardiovascular |
| Adrenaline |
- |
Human Serum |
- |
- |
ELISA |
1.50 - 150 ng/mL |
Cardiovascular |
| Ala TOP |
- |
Serum |
- |
- |
Immulite 2000 |
- |
Allergy & Immunology |
| Albumin |
- |
Human Urine |
- |
- |
RIA |
2.50 - 60.0 µg/mL |
Nefrology |
| Albumin |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
10 - 60 g/L |
Hepatic Diseases / Nutritional assessment |
| Albumin |
- |
Urine |
- |
- |
Immulite 2000 |
2.5 - 60 µg/mlL |
Diabetes |
| Aldosteron |
- |
Human Plasma / Serum |
- |
- |
RIA |
69.0 - 3330 pmol/mL |
Endocrinology |
| Alitretinoin, tretinoin, isotretinoin, 4-oxoalitretinoin, 4-oxotretinoin, 4-oxo-isotretinoin |
Human |
Plasma |
EDTA |
- |
HPLC |
2.00 - 300 ng/ml |
- |
| Alk Phosphatase AMP |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1100 U/L |
Bone Metabolism / Hepatic Diseases |
| Alk Phosphatase DEA |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1600 U/L |
Bone Metabolism / Hepatic Diseases |
| Alpha 1 Microglobulin |
- |
Human Urine |
- |
- |
Immage |
0.400 - 8.0 mg/dL |
Nefrology |
| Alpha 2 Macroglobulin |
- |
Human serum |
- |
- |
Immage |
40.0 - 400 mg/dL |
Nefrology |
| Alpha Foetoprotein |
- |
Human Serum |
- |
- |
ELISA |
0.200 - 500 IU/mL |
Oncology |
| Alpha GST |
- |
Human Serum |
- |
- |
ELISA |
1.25 - 40.0 µg/L |
Hepatology |
| Alpha GST |
- |
Human Urine |
- |
- |
ELISA |
1.25 - 40.0 µg/L |
Hepatology |
| Alpha- 1-Antitrypsin |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.05 - [5.0 - 5.40] g/L |
Other Speciality Analytes |
| Alpha-1-Acid Glycoprotein (A1AG) |
- |
Human Serum |
- |
- |
Immage |
35-300 mg/dL |
Hepatology |
| Alpha-1-Antitrypsin |
- |
Human serum |
- |
- |
Immage |
60.0 - 600 mg/dL |
Hepatology |
| Alprazolam |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 50.0 ng/ml |
- |
| Ambasilide |
Human |
Urine |
None |
- |
HPLC |
2.50 - 400 ng/ml |
- |
| Amitriptyline, nortriptyline |
Human |
Plasma |
EDTA |
- |
HPLC |
1.00 - 100 ng/ml |
- |
| Ammonia |
- |
Plasma |
- |
- |
ADVIA 1800 |
5.3 - 767 µmol/L |
Other Speciality Analytes |
| Amoxicillin |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 10.0 µg/ml |
- |
| Amoxicillin |
Human |
Saliva |
None |
- |
HPLC |
0.500 - 10.0 µg/ml |
- |
| Amphetamines (AMPHET) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 1000, < 1000 ng/mL |
Toxicology / Drugs of Abuse |
| Amylase |
- |
Serum, Li Heparin Plasma, Urine |
- |
- |
ADVIA 1800 |
0 - 1500 U/L |
Pancreatic Disease |
| Amylase Electroforese |
- |
Human Serum |
- |
- |
Paragon System |
- |
General |
| Amyloid Beta |
- |
Human Plasma / Serum |
- |
- |
ELISA |
0.00 - 1000 pg/mL |
CNS |
| Androsteendion |
- |
Serum, Heparin Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.3 - 10 ng/mL, 1.04 - 35 nmol/L |
Fertility |
| Androstenedione |
- |
Human Serum |
- |
- |
RIA |
0.350 - 21.0 nmol/L |
Endocrinology |
| Androstenedione |
- |
Human Plasma / Serum |
- |
- |
ELISA |
0.10 - 10.0 ng/mL |
Endocrinology |
| Angiotensin I |
- |
Human Plasma |
- |
- |
RIA |
2.50 - 320 pg/mL |
Cardiovascular |
| Angiotensin II |
- |
Human Plasma |
- |
- |
RIA |
2.50 - 320 pg/mL |
Cardiovascular |
| Angiotensin II |
- |
Human Plasma |
- |
- |
RIA |
1.9 - 478 pmol/L |
Cardiovascular |
| Angiotensin converting enzyme |
- |
Human Serum |
- |
- |
RIA |
1.42 - 45.3 ACE units |
Cardiovascular |
| Anti HAV IgM |
- |
Serum, Heparine Plasma, Na Citrate EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| Anti HBs |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
3 - 2000 mIU/mL |
Serology |
| Anti Hbc IgM |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
2 - 100 U/mL |
Serology |
| Anti TG |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
20 - 3000 IU/mL |
Thyroid |
| Anti TPO |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
10 - 1000 IU/mL |
Thyroid |
| Anti Thrombin |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Anti Thrombin |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Anti Thrombin 3 |
- |
Human EDTA Plasma |
- |
- |
Immage |
5.00 - 300 mg/dL |
Coagulation |
| Anti Thrombin 3 |
- |
Human EDTA Plasma |
- |
- |
Immage |
5.00 - 300 mg/dL |
Coagulation |
| Anti-HBc |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| Anti-HBs |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
1 - 1000 mIU/mL |
Infectious Disease |
| Anti-Streptolysin O |
- |
Serum |
- |
- |
ADVIA 1800 |
65 - 525 IU/mL |
Autoimmune / Rheumatoid Disease |
| Anti-Streptolysin O_2 |
- |
Serum, EDTA Plasma, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
25 - 1000 IU/mL |
Autoimmune / Rheumatoid Disease |
| Antigen-specific antibody response |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Antipyrine |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 20.0 µg/ml |
- |
| Antistreptolysin O |
- |
Human Plasma / Serum |
- |
- |
Immage |
25.0 - 800 IU/mL |
Allergy & Immunology |
| Apo-B100 |
- |
Human Serum |
- |
- |
ELISA |
70.0 - 700 ng/mL |
Metabolism |
| Apo-B48 |
- |
Human Serum |
- |
- |
ELISA |
2.50 - 160 ng/mL |
Metabolism |
| Apolipoprotein A1 |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.15 - [2.0 - 2.6] g/L |
Cardiovascular Risk Assessment |
| Apolipoprotein A1 |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.15 - [2.0 - 2.6] g/L |
Hepatic Diseases |
| Apolipoprotein A1 |
- |
Human Serum |
- |
- |
Immage |
25.0 - 450 mg/dL |
Metabolism |
| Apolipoprotein B |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.15 - [2.0 - 2.6] g/L |
Cardiovascular Risk Assessment |
| Apolipoprotein B |
- |
Human Serum |
- |
- |
Immage |
35.0 - 450 mg/dL |
Metabolism |
| Apolipoprotein E |
- |
Human Serum |
- |
- |
Immage |
7.40 - 128 mg/L |
Metabolism |
| Aquaporin 2 (AQP-2) |
- |
Human Urine |
- |
- |
ELISA |
0.300 - 15.0 ng/mL |
Endocrinology |
| Arachidon Acid |
- |
Human Plasma |
- |
- |
PAP-4 |
- |
Cardiovascular |
| Arginine-vasopressin (AVP, ADH) |
- |
Human Plasma |
- |
- |
RIA |
1.00 - 64.0 pg/mL |
Endocrinology |
| Arteether |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
5.00 - 500 ng/ml |
- |
| Ascorbic acid |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 50.0 µg/ml |
- |
| Atenolol |
Human |
Urine |
None |
- |
HPLC |
1.00 – 60.0 mg/l |
- |
| Atenolol |
Human |
Plasma |
Heparin |
- |
HPLC |
15.0-1500 ng/ml |
- |
| Azatadine |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.0500 - 25.0 ng/ml |
- |
| Azatadine |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
2.50 - 1000 pg/ml |
- |
| B- and NK-cells (CD3/CD16+CD56/ CD45/ CD19) |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunophenotyping |
| B-nag |
- |
Urine |
- |
- |
ADVIA 1800 |
- |
Diabetes |
| BNP |
- |
Human Plasma |
- |
- |
RIA |
117 - 627 pg/mL |
Cardiovascular |
| BNP |
- |
EDTA Plasma |
- |
- |
ADVIA Centaur |
0.58 - 1445 pmol/L |
Cardiac |
| BNP |
- |
EDTA Plasma |
- |
- |
ADVIA Centaur |
<2.0 - 5000 pg/mL |
Cardiac |
| BR |
- |
Serum |
- |
- |
ADVIA Centaur |
3.5 - 450 U/mL |
Oncology |
| BR-MA (CA 15.3) |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
1 - 300 U/mL |
Oncology |
| Barbiturate (BARB) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 200, < 200 ng/mL |
Toxicology / Drugs of Abuse |
| Benzodiazepine (BENZO) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 200, < 200 ng/mL |
Toxicology / Drugs of Abuse |
| Benzylpenicillin |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
2.00-2000 ng/ml |
- |
| Beta-2 microglobulin |
- |
Serum, Heparine Plasma, EDTA Plasma, Urine |
- |
- |
Immulite 2000 |
4.0 - 500 ng/mL |
Oncology |
| Beta-2-Microglobulin |
- |
Human Serum / Urine |
- |
- |
IRMA |
± 10.0 miu/mL |
Nefrology |
| Beta-2-Microglobulin |
- |
Human Plasma / Serum |
- |
- |
Immage |
0.0500 - 20.0 mg/dL |
Haematology |
| Beta-Trace-Protein |
- |
Human Serum |
- |
- |
Immage |
0.230 - 14.0 mg/L |
Nefrology |
| Bexarotene (low) |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500-150 ng/ml |
- |
| Bexarotene (targretin) |
Human |
Plasma |
Heparin |
- |
HPLC |
3.00-1500 ng/ml |
- |
| Bilirubin_2 Total |
- |
Serum |
- |
- |
ADVIA 1800 |
0 - 598.15 µmol/L |
Hepatic Diseases |
| Bilirubin_2, Direct |
- |
Serum |
- |
- |
ADVIA 1800 |
0 - 256.35 µmol/L |
Hepatic Diseases |
| Bone-specific alkaline phosphatase |
- |
Human Serum |
- |
- |
Immuno/Enzym |
7.00 - 90.0 µg/L |
Bonemarkers |
| Bradykinin |
- |
Human Plasma |
- |
- |
ELISA |
- |
Hypertension |
| Bromovinyluridine |
Rat |
Plasma |
Heparin |
- |
HPLC |
50.0 - 10000 ng/ml |
- |
| Brompheniramine |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.0500 - 25.0 ng/ml |
- |
| Bumetanide |
Human |
Urine |
None |
- |
HPLC |
20.0 - 500 ng/ml |
- |
| Bumetanide |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 100 ng/ml |
- |
| C-Peptide |
- |
Serum, Heparine Plasma, EDTA Plasma*, NaF Plasma*, Urine |
- |
- |
Immulite 2000 |
0.5 - 7 ng/mL, 166 - 2317 pmol/L, 0.17 - 2.3 nmol/L |
Diabetes |
| C-Reactive Protein (CRP) |
- |
Human Serum |
- |
- |
Immage |
0.100 - 96.0 mg/dL |
Cardiovascular |
| C-Reactive Protein (CRP) |
- |
Serum |
- |
- |
ADVIA 1800 |
5 - [195- 205] mg/L |
Inflammation |
| C-Reactive Protein (CRP_2) |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
4 to [304 – 336] mg/L |
Inflammation |
| C-Reactive Protein (wrCRP) |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.12 - [156 - 164] mg/L |
Inflammation |
| C-peptide |
- |
Human Serum |
- |
- |
ELISA |
0.075 - 7.24 pmol/mL |
Metabolism |
| C-telopeptide |
- |
Human Urine |
- |
- |
ELISA |
0.0800 - 5.40 ug/mL |
Metabolism |
| C1-Esterase inhibitor |
- |
Human Serum |
- |
- |
Immage |
54.0 750 mg/L |
Allergy & Immunology |
| C1Q component Factor |
- |
Human Serum |
- |
- |
Immage |
40.0 - 600 mg/L |
Allergy & Immunology |
| C3 |
- |
Serum |
- |
- |
ADVIA 1800 |
0.01 - [5.0 -5.5] g/L |
Inflammation |
| C3A des arg |
- |
Human Plasma |
- |
- |
ELISA |
0.313 - 20 ng/mL |
Allergy & Immunology |
| C4 |
- |
Serum |
- |
- |
ADVIA 1800 |
0.01 - [1.4 - 1.5] g/L |
Inflammation |
| C5A des-arg |
- |
Human Plasma |
- |
- |
ELISA |
0.0781 - 5.00 ng/mL |
Allergy & Immunology |
| CA 125 II |
- |
Serum |
- |
- |
ADVIA Centaur |
2 - 600 U/mL |
Oncology |
| CA 15.3 |
- |
Serum |
- |
- |
ADVIA Centaur |
0.5 - 200 U/mL |
Oncology |
| CA 19.9 |
- |
Serum |
- |
- |
ADVIA Centaur |
1.2 - 700 U/mL |
Oncology |
| CBG |
- |
Human Serum |
- |
- |
RIA |
0.440 - 8.20 µg/mL |
Endocrinology |
| CD-14 |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| CD-23 |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| CD11B and CD62L expression on monocytes and granulocytes |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CD16 expression on granulocytes |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CD18, CD11b, CD62L and CD45 expression on granulocytes |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CD25 expression on CD4 and CD8 T-cells |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CD34 |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CD40 expression in CD19 positive B-cells |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CD63 determination on basophilic cells |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CD63 expression on basophilic cells |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| CEA |
- |
Serum |
- |
- |
ADVIA Centaur |
0.5 - 100 ng/mL |
Oncology |
| CEA |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
0.2 - 550 ng/mL |
Oncology |
| CK-MB |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
0.5 - 500 ng/mL |
Cardiovascular |
| CKMB |
- |
Serum, Heparin Plasma |
- |
- |
ADVIA 1800 |
- |
Cardiac |
| CMV IgG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| CMV-IgM |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| CRP |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
0.01 - 15 mg/dL, 0.1 - 150 mg/L |
Cardiovascular |
| CSF-1 |
- |
Human Plasma |
- |
- |
ELISA |
31.2 - 2000 pg/mL |
Immunology |
| CTX-II |
- |
Human Urine |
- |
- |
ELISA |
0.460 - 8.08 µg/mL |
Bonemarkers |
| Caffeine metabolites 1MX and AAMU |
Human |
Urine |
None |
- |
HPLC |
1.00 - 50.0 µg/ml |
- |
| Caffeine, Paraxanthine |
Human |
Plasma |
EDTA |
- |
HPLC |
0.100 - 10.0, µg/ml |
- |
| Calcitonine |
- |
Serum and Heparin Plasma stored on ice, EDTA Plasma* |
- |
- |
Immulite 2000 |
2 - 2000 pg/mL, 0.6 - 585 pmol/L |
Bone Metabolism |
| Calcium (CPC) |
- |
Serum, Li Heparin Plasma, Urine |
- |
- |
ADVIA 1800 |
0.25 - 3.75 mmol/L |
Bone Metabolism |
| Calcium_2 (Arsenazo) |
- |
Serum, Li Heparin Plasma, Urine |
- |
- |
ADVIA 1800 |
0.25 - 4 mmol/L |
Bone Metabolism |
| Candesartan (CV11974) |
Human |
Serum |
None |
- |
HPLC |
2.00 - 200 ng/ml |
- |
| Canine T4 |
- |
Canine Serum |
- |
- |
Immulite 2000 |
0.5 - 15 µg/dL, 6.4 - 193 nmol/L |
Canine |
| Canine TSH |
- |
Canine Serum |
- |
- |
Immulite 2000 |
0.03 - 12 ng/mL |
Canine |
| Cannabinoid (THC) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 50, < 50 ng/mL |
Toxicology / Drugs of Abuse |
| Captopril (free) |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 1000 ng/ml |
- |
| Captopril (total) |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 1000 ng/ml |
- |
| Carbamazepine |
- |
Serum |
- |
- |
ADVIA Centaur |
0.25 - 18 ug/mL |
TDM |
| Carbamazepine |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
1.06 - 76.1 umol/L |
TDM |
| Carbamazepine |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
2.3 - [ 76.1 - 93.1] µmol/L |
Therapeutic Drug Monitoring |
| Carbamazepine, carbamazepine-10,11-epoxide |
Human |
Plasma |
Heparin |
- |
HPLC |
0.0500 - 10.0 µg/ml |
- |
| Carbamazipne |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
1.25 - 20 µg/mL, 5.29 - 85 µmol/L |
Antibiotics |
| Carbon Dioxide-Liquid |
- |
Serum |
- |
- |
ADVIA 1800 |
10 - 40 mmol/L |
Electrolytes |
| Cefpirome |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 250 µg/ml |
- |
| Ceruloplasmin |
- |
Human Serum |
- |
- |
Immage |
2.00 - 4320 mg/dL |
Metabolism |
| Chloride ISE |
- |
Urine |
- |
- |
ADVIA 1800 |
15 - 400 mmol/L |
Electrolytes |
| Chloride ISE |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
15 - 200 mmol/L |
Electrolytes |
| Chloroquine |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 1000 ng/ml |
- |
| Chlorpheniramine |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.0500 - 25.0 ng/ml |
- |
| Cholecystokinin (CCK) |
- |
Human Plasma |
- |
- |
RIA |
0.78 - 25.0 pmol/L |
Metabolism |
| Cholesterol |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 675 mg/dL |
Cardiovascular Risk Assessment |
| Cholesterol (total) |
- |
Human Plasma |
- |
- |
LC-MS/MS |
1.00 - 15.0 mmol/L |
General |
| Cholinesterase |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
1,500 - 30,000 U/L |
Other Speciality Analytes |
| Cholinesterase Inhibition |
- |
Human Rbc |
- |
- |
Enzyme Inhibition |
- |
CNS |
| Cholinesterase Inhibition |
- |
Human CSF |
- |
- |
Enzyme Inhibition |
- |
CNS |
| Chorionic Gonadotropin, beta subunit |
- |
Human Serum |
- |
- |
ELISA |
0.00 - 100 IU/mL |
Oncology |
| Chorionic Gonadotropin,free |
- |
Human Serum |
- |
- |
RIA |
0.10 - 100 mIU/mL |
Oncology |
| Chromogranin A |
- |
Human Plasma |
- |
- |
RIA |
0.156 - 5.00 nmol/L |
Endocrinology |
| Cimetidine |
Human |
Urine |
None |
- |
HPLC |
10.0 - 500 µg/ml |
- |
| Cimetidine |
Human |
Plasma |
Heparin |
- |
HPLC |
0.100 - 5.00 µg/ml |
- |
| Cinnarizine |
Human |
Plasma |
Heparin |
- |
HPLC |
2.50 - 100 ng/ml |
- |
| Cisapride, ticalopride |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
1.00 - 200 ng/ml |
- |
| Clarithromycin, 14-hydroxy-clarithromycin |
Human |
Plasma |
Heparin |
- |
HPLC |
50.0 - 5000 ng/ml |
- |
| Clofibric acid |
Monkey |
Plasma |
Heparin |
- |
HPLC |
1.00 - 500 µg/ml |
- |
| Clomipramine, desmethylclomipramine |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 100 ng/ml |
- |
| Clonazepam / 7-acetamido-clonazepam / 7-amino-clonazepam / clopidogrel carboxylic acid |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 60.0 / 2.50 - 50.0 /2.50 - 50.0 / 5.00 - 5000 ng/ml |
- |
| Cloprednol |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 500 ng/ml |
- |
| Cocaine Metabolite (COCAIN) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 300, < 300 ng/mL |
Toxicology / Drugs of Abuse |
| Codeine |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 200 ng/ml |
- |
| Collagen |
- |
Human Plasma |
- |
- |
PAP-4 |
- |
Coagulation |
| Complement C3 |
- |
Human Serum |
- |
- |
Immage |
5.83-12600mg/dL |
Allergy & Immunology |
| Complement C3 |
- |
Human Plasma |
- |
- |
ELISA |
5.00 - 500 ng/mL |
Inflammation |
| Complement C4 |
- |
Human Serum |
- |
- |
Immage |
1.67-4680mg/dL |
Allergy & Immunology |
| Complement C4 |
- |
Human Serum |
- |
- |
Immage |
1.67 - 4680 mg/dL |
Allergy & Immunology |
| Cortisol |
- |
Human Plasma |
- |
- |
RIA |
10.0 - 500 µg/L |
Endocrinology |
| Cortisol |
- |
Human Urine |
- |
- |
LC-MS/MS |
1.00 - 100 ng/ml |
Endocrinology |
| Cortisol |
- |
Human Urine |
- |
- |
ELISA |
10.0 - 300 ng/mL |
Endocrinology |
| Cortisol |
- |
Urine |
- |
- |
ADVIA Centaur |
5.5 - 2069 nmol/L |
Other |
| Cortisol |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
1 - 50 µg/dL, 28 - 1380 nmol/L |
Diverse |
| Cortisol |
- |
Serum |
- |
- |
ADVIA Centaur |
0.2 - 75 ug/dL |
Other |
| Cortisol / 6ß-hydroxycortisol |
Human |
Urine |
None |
- |
LC-MS/MS |
1.00 - 100 / 5.00 - 500 ng/ml |
- |
| Creatine Kinase |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1300 U/L |
Cardiovascular Acute Care |
| Creatine Kinase Electroforese |
- |
Human Serum |
- |
- |
Paragon System |
- |
Cardiovascular |
| Creatinine (Jaffe) |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
8.84 - 2210 µmol/L |
Nephropathies |
| Creatinine (Jaffe) |
- |
Urine |
- |
- |
ADVIA 1800 |
132.6 - 26520 µmol/L |
Nephropathies |
| Creatinine_2, Enzyme |
- |
Serum, Li Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA 1800 |
9 - 2652 µmol/L |
Nephropathies |
| Creatinine_2, Enzyme |
- |
Urine |
- |
- |
ADVIA 1800 |
90 - 21,658 µmol/L |
Nephropathies |
| Cromoglycate |
Human |
Urine |
None |
- |
HPLC |
100 - 4000 ng/ml |
- |
| Cyclosporin |
- |
Human Blood |
- |
- |
LC/MS |
5.00 - 5000 ng/mL |
Allergy & Immunology |
| Cyclosporine |
Human |
Whole Blood |
EDTA |
- |
LC-MS/MS |
5.00 - 5000 ng/ml |
- |
| Cyproteron acetate |
- |
Human Plasma |
- |
- |
HPLC |
11.1 - 556 ng/mL |
Endocrinology |
| Cyproteron acetate |
Human |
Plasma |
Heparin |
- |
HPLC |
11.1 - 556.0 ng/ml |
- |
| Cystatin C |
- |
Human Serum |
- |
- |
Immage |
0.2-11.0 mg/L |
Nefrology |
| Cytarabine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Cytidine Deaminase Act. Protein analysis |
- |
Human White Blood Cells (Lysed) |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Cytidine Deaminase Act. Uridine |
- |
Human Blood Mononucl. Leukocytes |
- |
- |
LC/MS |
- |
Allergy & Immunology |
| D- Dimer |
- |
Na Citrate Heparin Plasma |
- |
- |
Immulite 2000 |
100 - 20000 ng FEU/mL |
Cardiovascular |
| D-Dimer |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| DHEA-SO4 |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
15 - 1000 µg/dL, 0.41 - 27 µmol/L |
Fertility |
| DHEA-s |
- |
Human Serum |
- |
- |
ELISA |
0.100 - 10.0 ug/mL |
Endocrinology |
| DOPAC, HVA |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
20.0 - 500 ng/ml |
- |
| DPP-IV |
- |
Human Serum |
- |
- |
Fluorometric |
- |
Metabolism |
| Debrisoquine, 4-hydroxydebrisoquine |
Human |
Urine |
None |
- |
HPLC |
0.250 - 20.0 µg/ml |
- |
| Decarboxy Prothrombin (PIVKA II) |
- |
Human plasma |
- |
- |
ELISA |
- |
Coagulation |
| Desacyl-ghrelin |
- |
Human plasma |
- |
- |
ELISA |
12.5 - 800 fmol/mL |
Metabolism |
| Dexamethasone |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| Dextromethorphan / dextrorphan |
Human |
Saliva |
None |
- |
HPLC |
10.0 - 1000 / 1.00 - 100 ng/ml |
- |
| Dextromethorphan / dextrorphan / 3-hydroxymorphinan / /3-methoxymorphinan |
Human |
Urine |
None |
- |
HPLC |
10.0 - 10000 / 25.0 - 10000 / 50.0 - 10000 / 2.50 - 5000 ng/ml |
- |
| Dextromoramide |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 200 ng/ml |
- |
| Diazepam |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Diclofenac |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 800 ng/ml |
- |
| Dif Screen 5 Part Diff. |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 3500 |
- |
General |
| Digitoxin |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
2.0 - 104.6 nmol/L |
TDM |
| Digitoxin |
- |
Serum |
- |
- |
ADVIA Centaur |
1.5 - 80 ng/mL |
TDM |
| Digitoxine |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
5 - 60 ng/mL, 6.5 - 78 nmol/L |
Antibiotics |
| Digoxin |
Human |
Urine |
None |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Digoxin |
- |
Serum |
- |
- |
ADVIA Centaur |
0.1 - 5.0 ng/mL |
TDM |
| Digoxin |
- |
Serum |
- |
- |
ADVIA Centaur |
0.128 - 6.4 nmol/L |
TDM |
| Digoxin |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.13 - 6.4 nmol/L |
Therapeutic Drug Monitoring |
| Digoxin, digoxigenin, monodigitoxoside, bisdigitoxoside |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 10.0 ng/ml |
- |
| Digoxin, digoxigenin, monodigitoxoside, bisdigitoxoside |
Human |
Urine |
None |
- |
LC-MS/MS |
0.500 - 200 ng/ml |
- |
| Digoxine |
- |
Human Serum |
- |
- |
RIA |
0.25 - 8.00 ng/mL |
General |
| Digoxine |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
0.5 - 8.0 ng/mL, 0.6 - 10 nmol/L |
Antibiotics |
| Dihydroartemisinin |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
5.00 - 500 ng/ml |
- |
| Dihydroartemisinin |
Rat/Dog |
Plasma |
Heparin |
- |
LC-MS/MS |
5.00 - 200 ng/ml |
- |
| Dihydrocodeine |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 100 ng/ml |
- |
| Dihydroepiandrosterone (DHA) |
- |
Human Plasma / Serum |
- |
- |
RIA |
- |
Endocrinology |
| Dihydroepiandrosterone Sulfate(DHEA) |
- |
Human Serum |
- |
- |
ELISA |
0.185 - 30.0 ng/mL |
Endocrinology |
| Dihydroepiandrosterone Sulfate(DHEA) |
- |
Human Serum |
- |
- |
RIA |
1.00 - 300 ng/mL |
Endocrinology |
| Dihydrotestosterone |
- |
Human Serum |
- |
- |
RIA |
25.0 - 12.00 pg/mL |
Endocrinology |
| Diltiazem / desacetyldiltiazem |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 100 / 2.00 - 50.0 ng/ml |
- |
| Diluted Pro Thrombin |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Dipeptidyl peptidase IV |
- |
Human Plasma |
- |
- |
ELISA |
0.200 - 500 ng/mL |
Metabolism |
| Direct HDL Cholesterol |
- |
Serum, Li Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA 1800 |
0.1 - 3.0 mmol/L |
Cardiovascular Acute Care |
| Direct LDL Cholesterol |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 25.9 mmol/L |
Cardiovascular Acute Care |
| Docetaxel |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
5.00 - 5000 ng/ml |
- |
| Domperidone |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| Domperidone |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 500 ng/ml |
- |
| Dopamine |
Human |
Urine |
None |
- |
HPLC |
10.0 - 3000 ng/ml |
- |
| Dopamine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 400 ng/ml |
- |
| Dopamine |
- |
Human Plasma |
- |
- |
HPLC |
10.0 - 3000 ng/mL |
CNS |
| Doxepin, nordoxepin |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 50.0 ng/ml |
- |
| Doxorubicin, doxorubicinol |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| Drospirenone |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 100 ng/ml |
- |
| Drospirenone |
Human |
Serum |
- |
- |
LC-MS/MS |
0.100 - 100 ng/ml |
- |
| EDN (EPX) |
- |
Human Urine |
- |
- |
ELISA |
0.250 - 16.0 ng/mL |
Inflammation |
| EHIV (1/O/2) |
- |
Serum, Li/Na Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0,05 - 50,0 Index |
Infectious Disease |
| EPO |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
1 - 200 mIU/mL |
Anemia / Iron Metabolism |
| Ecarine Cloting Time |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Elastase-1 |
- |
Human Faeces |
- |
- |
ELISA |
50.0 - 500 ug/g |
Metabolism |
| Eltoprazine |
Human |
Urine |
None |
- |
HPLC |
2 - 100 ng/ml |
- |
| Enalapril, enalaprilat |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.500 - 250 ng/ml |
- |
| Endothelin-1 |
- |
Human Plasma |
- |
- |
ELISA |
1.23 - 10.6 fmol/mL |
Cardiovascular |
| Eosinophil Cationic Protein |
- |
Serum, Heparine plasma*, EDTA Plasma* |
- |
- |
Immulite 2000 |
1 - 2000 ng/mL |
Allergy & Immunology |
| Eotaxin |
- |
Human Plasma / Serum |
- |
- |
ELISA |
7.80 - 500 pg/mL |
Respiratory |
| Epinephrine |
- |
Human Plasma |
- |
- |
PAP-4 |
- |
General |
| Epirubicin, epirubicinol |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
1.00 - 250 ng/ml |
- |
| Equilin |
- |
Human Serum |
- |
- |
ELISA |
- |
CNS |
| Erlotinib |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
3.00 - 3000 ng/ml |
- |
| Erythrocyten |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 3500 |
- |
General |
| Erythromycine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
20.0 - 5000.0 ng/ml |
- |
| Erythropoetin |
- |
Human Serum / Urine |
- |
- |
IRMA |
10.00 - 1000 ng/mL |
Haematology |
| Erythropoetin |
- |
Human Serum |
- |
- |
ELISA |
2.00 - 64.0 mU/mL |
Haematology |
| EstraDiol |
- |
Human Plasma |
- |
- |
LC-MS/MS |
2.00 - 2000 pg/mL |
Endocrinology |
| EstraDiol |
- |
Human Plasma / Serum |
- |
- |
RIA |
10.0 - 1000 pg/mL |
Endocrinology |
| EstraDiol |
- |
Human Serum |
- |
- |
RIA |
0.020 - 1.84 nmol/L |
Endocrinology |
| EstraDiol (total) |
- |
Human Urine |
- |
- |
HPLC-RIA |
0.062 - 5.00 nmol/L |
Endocrinology |
| EstraDiol 17 beta |
- |
Human Serum |
- |
- |
RIA |
10.0 - 1000 pg/mL |
Endocrinology |
| Estradiol |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
2.00 - 2000 pg/ml |
- |
| Estradiol |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
20 - 2000 pg/mL, 73 - 7342 pmol/L |
Fertility |
| Estradiol-6 |
- |
Serum |
- |
- |
ADVIA Centaur |
10 - 1000 pg/mL |
Fertility |
| Estradiol-6 III |
- |
Serum |
- |
- |
ADVIA Centaur |
7 - 1000 pg/mL |
Fertility |
| Estriol |
- |
Human Plasma / Serum |
- |
- |
RIA |
10.0 - 1000 pg/mL |
Endocrinology |
| Estrone |
- |
Human Serum |
- |
- |
RIA |
0.0500 - 5.00 µg/L |
Endocrinology |
| Estrone (total) |
- |
Human Serum |
- |
- |
ELISA |
25.0 - 2000 pg/mL |
Endocrinology |
| Ethambutol |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
50.0 - 10000 ng/ml |
- |
| Ethanol |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
2.2-108.5 mmol/L |
Drugs of Abuse / Toxicology |
| Ethinylestradiol |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
2.00-1000 pg/ml |
- |
| Ethinylestradiol |
Human |
Serum |
- |
- |
LC-MS/MS |
2.00 - 1000 pg/ml |
- |
| Ethylglucuronide (EtG) |
- |
Serum |
- |
- |
ADVIA 1800 |
- |
Drugs of Abuse / Toxicology |
| Ethynylestradiol |
- |
Human Plasma |
- |
- |
LC-MS/MS |
10.0 - 1000 pg/mL |
Endocrinology |
| Exemestane, 17-hydroxyexemestane |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.100 - 25.0 ng/ml |
- |
| FSH |
- |
Serum |
- |
- |
ADVIA Centaur |
0.3 - 200 mlU/mL |
Fertility |
| FSH |
- |
Serum, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.1 - 170 mIU/mL |
Fertility |
| FT3 |
- |
Serum |
- |
- |
ADVIA Centaur |
0.2 - 20 pg/mL |
Thyroid |
| FT3 |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
1 - 40 pg/mL, 1.5 - 61 pmol/L |
Thyroid |
| FT4 |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.3 - 6 ng/dL, 3.9 - 77.2 pmol/L |
Thyroid |
| Factor II |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Factor IX |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Factor V |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Factor VII |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Factor XI |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Factor XII |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Factor Xa |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Felbamate, 2-hydroxyfelbamate, p-hydroxyfelbamate, felbamate monocarbonate |
Human |
Urine |
None |
- |
HPLC |
1.00 - 200 µg/ml |
- |
| Fenofibric Acid |
- |
Human Plasma |
- |
- |
LC/MS |
- |
General |
| Ferritin |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.5 - 1650 ng/mL |
Anemia |
| Ferritin |
- |
Human Serum |
- |
- |
ELISA |
- 1500 ng/mL |
Haematology |
| Ferritin |
- |
Human Serum |
- |
- |
Immage |
5.00 - 10,000 ng/mL |
Haematology |
| Ferritin |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
1.5 - 1500 ng/mL |
Haematology |
| Fibrinogen-C |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Fibronectin |
- |
Human EDTA Plasma |
- |
- |
Immage |
60.0 - 1200 mg/L |
Haematology |
| Fluoxetine, norfluoxetine |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 500 ng/ml |
- |
| Flurbiprofen |
Human |
Plasma |
EDTA |
- |
HPLC |
100 - 20000 ng/ml |
- |
| Flurbiprofen |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
50.0 - 1000 and 1000 - 10000 ng/ml |
- |
| Fluvastatin |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Folate |
- |
Serum, Heparine Plasma, EDTA Plasma*, Whole Blood for Erythrocytair Folate |
- |
- |
Immulite 2000 |
1 - 15 ng/mL, 2.3 - 34 nmol/L |
Haematology |
| Folate BA |
- |
Serum, Whole Blood |
- |
- |
ADVIA Centaur |
0.35 - 24 ng/mL |
Anemia |
| Follicle Stimulating Hormone (FSH) |
- |
Human Serum |
- |
- |
ELISA |
0.0500 - 40.0 mIU/mL |
Endocrinology |
| Follicle Stimulating Hormone (FSH) |
- |
Human Serum |
- |
- |
ELISA |
5.00 - 146 mlU/mL |
Endocrinology |
| Follicle Stimulating Hormone (FSH) |
- |
Human Urine |
- |
- |
RIA |
2.00 - 100 mIU/mL |
Endocrinology |
| Follicle Stimulating Hormone (FSH) |
- |
Human Plasma |
- |
- |
ELISA |
0.500 - 30.0 mIU/mL |
Endocrinology |
| FrT4 |
- |
Serum |
- |
- |
ADVIA Centaur |
0.1 - 12 ng/dL |
Thyroid |
| Fraxatin (161-180) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Metabolism |
| Free B-HCG |
- |
Serum |
- |
- |
Immulite 2000 |
0.1 - 200 ng/mL |
Fertility |
| Free Estriol |
- |
Serum |
- |
- |
Immulite 2000 |
0.25 - 30 ng/mL, 0.87 - 104 nmol/L |
Fertility |
| Free Fatty Acid (FFA) |
- |
Serum |
- |
- |
ADVIA 1800 |
- |
Metabolism |
| Free PSA |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
0.05 - 25 ng/mL |
Oncology |
| Free Triiodothyronine 3 FT3 |
- |
Human Serum |
- |
- |
ELISA |
0.00 - 19.0 pg/mL |
Endocrinology |
| Free Triiodothyronine 4 FT4 |
- |
Human Serum |
- |
- |
ELISA |
0.00 - 7.00 ng/dL |
Endocrinology |
| Fructosamine |
- |
Human Serum |
- |
- |
ELISA |
15.0 - 1730 umol/L |
Metabolism |
| Fructosamine |
- |
serum |
- |
- |
ADVIA 1800 |
- |
Diabetes |
| Furosemide |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 1000 ng/ml |
- |
| Furosemide |
Human |
Urine |
None |
- |
HPLC |
0.500 - 10.0 µg/ml |
- |
| G-CSF |
- |
Human Plasma |
- |
- |
ELISA |
39.1 - 2500 pg/mL |
Oncology |
| GAD-AB (antib. to Glutamic acid Decarboxylase) |
- |
Human Serum |
- |
- |
RIA |
- |
Metabolism |
| GGT |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1200 U/L |
Hepatic Diseases |
| GI-MA ( CA 19.9) |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
2.5 - 1000 U/mL |
Oncology |
| GLDH |
- |
Serum |
- |
- |
ADVIA 1800 |
- |
Hepatic Diseases |
| GM-CSF |
- |
Human Plasma |
- |
- |
ELISA |
50.0 - 2000 pg/mL |
Haematology |
| Gabapentine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
50.0 - 10000 ng/ml |
- |
| Galantamine |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| Ganciclovir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
50.0 - 10000.0 ng/ml |
- |
| Gastrin |
- |
Human Serum |
- |
- |
RIA |
15.6 - 500 pmol/L |
Metabolism |
| Gastrine |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
10 - 1000 pg/mL |
Diverse |
| Gemfibrozil |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 100 ug/ml |
- |
| General white blood cell phenotyping |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunophenotyping |
| Gentamicin |
- |
Serum |
- |
- |
ADVIA Centaur |
0.17 - 12 ug/mL |
TDM |
| Gentamicin |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.5 - [22.59 - 27.59] µmol/L |
Therapeutic Drug Monitoring |
| Gentamicin |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.36 - 25.1 umol/L |
TDM |
| Gentamicin |
Human |
Serum |
None |
- |
LC-MS/MS |
0.0500 - 20.0 µg/ml |
- |
| Glibenclamide (glyburide) |
Human |
Plasma |
EDTA |
- |
HPLC |
1.00 - 1000 ng/ml |
- |
| Glicentin |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Gastrointestinal |
| Glimepiride |
Human |
Plasma |
EDTA/ Heparin |
- |
LC-MS/MS |
1.00 - 1000 ng/ml |
- |
| Glucagon |
- |
Human Serum albumin |
- |
- |
RIA |
25.0 - 1000 pg/mL |
Metabolism |
| Glucagon like peptide 1 (GLP-1) |
- |
Human Plasma (Dpp-4) |
- |
- |
ELISA |
2.00 - 100 pM |
Metabolism |
| Glucagon like peptide 1 total (GLP-1 total) |
- |
Human Plasma |
- |
- |
RIA |
3.33 - 333 pM |
Metabolism |
| Glucagon like peptide 2 (GLP-2) |
- |
Human Plasma |
- |
- |
ELISA |
0.400 - 100 ng/mL |
Metabolism |
| Glucaric acid |
- |
Human Urine |
- |
- |
Spectrofotometric |
2.10 - 31.5 ug/mL |
Metabolism |
| Glucose Hexokinase |
- |
Serum, Plasma, Urine |
- |
- |
ADVIA 1800 |
0 - 38.5 mmol/L |
Diabetes |
| Glucose Oxidase |
- |
Serum, Plasma, Urine |
- |
- |
ADVIA 1800 |
0 - 41.25 mmol/L |
Diabetes |
| Glucose-dep. Insulinotropic peptide (GIP) |
- |
Human Plasma (aprotinin)//Serum |
- |
- |
ELISA |
8.2 - 666.7 pg/mL |
Metabolism |
| Glutathion |
- |
Human Plasma |
- |
- |
ELISA |
30.0 - 500 uM |
Hepatology |
| Glyburide |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 1000 ng/ml |
- |
| Granulocyte Colony Stimulating factor (G-CSF) |
- |
Human Plasma |
- |
- |
ELISA |
50.0 - 2000 pg/mL |
Oncology |
| Growth Hormone |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
0.05 - 40 ng/mL, 0.12 – 96 mIU/L |
Diverse |
| H-FABP |
- |
Human serum |
- |
- |
ELISA |
200 - 10000 pg/mL |
Cardiovascular |
| HBc IgM |
- |
Serum, Li/Na Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0,05 - 9,00 Index |
Infectious Disease |
| HBc Total |
- |
Serum, EDTA Plasma |
- |
- |
ADVIA Centaur |
0,07 - 8,00 Index |
Infectious Disease |
| HBsAg |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| HBsAg |
- |
Serum, Li Heparin Plasma, Na Heparin Plasma, EDTA Plasma, Citrate Plasma |
- |
- |
ADVIA Centaur |
0,1 - 1000 Index |
Infectious Disease |
| HBsAg Conf |
- |
Serum, Li Heparin Plasma, EDTA Plasma, Citrate Plasma |
- |
- |
ADVIA Centaur |
0,1 - 1000 Index |
Infectious Disease |
| HCG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
1 - 5000 mIU/mL |
Fertility |
| HCV |
- |
Serum, Li/Na Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0,0 - 11,0 Index |
Infectious Disease |
| HDL and LDL/VLDL cholesterol |
- |
Human Serum |
- |
- |
Colorimetry |
- |
Cardiovascular |
| HMG-CoA reductase |
- |
Human Serum |
- |
- |
Enzymatic |
- |
Cardiovascular |
| Haemoprexin |
- |
Human Serum |
- |
- |
Immage |
282 - 3960 mg/L |
Haematology |
| Haptoglobin |
- |
Serum |
- |
- |
ADVIA 1800 |
0.01 - [3.4 - 4.1] g/L |
Anemia / Iron Metabolism |
| Haptoglobin |
- |
Human Serum |
- |
- |
Immage |
5.83 - 12,600 mg/dL |
Haematology |
| Haptoglobin |
- |
Human Serum |
- |
- |
Immage |
35.0 - 350 mg/dL |
Haematology |
| Heamatocrit |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 4000 |
- |
General |
| Heamoglobin |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 4000 |
0.600 - 15.5 mmol/L |
General |
| Heat Shock Protein 27 (Hsp27) |
- |
Human Serum |
- |
- |
ELISA |
0.390 - 25.0 ng/mL |
General |
| Heat Shock Protein 60 (Hsp60) |
- |
Human Serum |
- |
- |
ELISA |
7.81 - 250 ng/mL |
General |
| Heat Shock Protein 70 (Hsp70) |
- |
Human Serum |
- |
- |
ELISA |
31.25 - 1,000 ng/mL |
General |
| HelicoBacter pylori IgG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
0.4 - 8.0 U/mL |
Serology |
| Heliobacter pylori antibodies |
- |
Human Serum |
- |
- |
ELISA |
0.200 - 6.50 |
Gastrointestinal |
| Heparin |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Her-2-neu |
- |
Serum |
- |
- |
ADVIA Centaur |
0.5 - 350 ng/mL |
Oncology |
| Herpes I & II IgG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| Homocysteine |
- |
Serum, Li Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
<0.5 - 65 µmol/L |
Cardiac |
| Homocysteine |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
2 - 50 µmol/L |
Cardiovascular |
| Human Parathyroid Hormone PTH |
- |
Human Plasma |
- |
- |
IRMA |
0.827 - 164 pmol/L |
Endocrinology |
| Human Parathyroid Hormone PTH (intact) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Endocrinology |
| Human growth hormone (hGH) |
- |
Human Serum |
- |
- |
RIA |
1.50 - 30.0 ug/L |
Endocrinology |
| Hydroxypropyl-ß-cyclodextrin |
Dog |
Plasma |
Heparin |
- |
HPLC |
5.00 - 500 µg/ml |
- |
| Hydroxypropyl-ß-cyclodextrin |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 500 µg/ml |
- |
| Hydroxypropyl-ß-cyclodextrin |
Human |
Urine |
None |
- |
HPLC |
25.0 - 2500 µg/ml |
- |
| IFN-gamma |
- |
Whole blood |
- |
- |
ELISA |
0.850 - 28 IU/mL |
Immunology |
| IGF-1 |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
25 - 1600 ng/mL |
Diverse |
| IGF-1 (insuline-like growth factor) |
- |
Human Serum |
- |
- |
IRMA |
4.50 - 640 ng/mL |
Metabolism |
| IGF-BP3 |
- |
Human Serum |
- |
- |
RIA |
0.625 - 40.0 ng/mL |
Endocrinology |
| IGFBP-3 |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
0.5 - 16 µg/mlL |
Diverse |
| IL-6 |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
2 - 1000 pg/mL |
Diverse |
| IL2R |
- |
Serum, EDTA Plasma* |
- |
- |
Immulite 2000 |
50 - 7500 U/mL |
Diverse |
| Ibuprofen |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 50.0 µg/ml |
- |
| Idazoxan |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
3.00 - 100 ng/ml |
- |
| Idebenone |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 500 ng/ml |
- |
| IgA |
- |
Human Plasma |
- |
- |
ELISA |
0.850 - 28.0 IU/mL |
Allergy & Immunology |
| IgA |
- |
Human Serum |
- |
- |
Immage |
6.70 - 25,200 mg/dL |
Respiratory |
| IgA sub 1 |
- |
Human Serum |
- |
- |
Immage |
582 - 2635 mg/L |
Allergy & Immunology |
| IgA sub 2 |
- |
Human Serum |
- |
- |
Immage |
122 - 1407 mg/L |
Allergy & Immunology |
| IgA_2 |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.033 - [5.4 - 6.6] g/L |
Polyclonal & monoclonal gammopathies / Immunology |
| IgD |
- |
Human Serum |
- |
- |
Immage |
12.5 - 176 U/mL |
Allergy & Immunology |
| IgE |
- |
Human Serum |
- |
- |
Immage |
25.0 - 2200 U/mL |
Allergy & Immunology |
| IgE |
- |
Human Serum |
- |
- |
Immage |
40.0 - 700 mg/dL |
Respiratory |
| IgG |
- |
Human Serum |
- |
- |
Immage |
33.30 - 21,600 mg/dL |
Allergy & Immunology |
| IgG |
- |
Human Serum |
- |
- |
RIA |
0.625 - 40.0 ng/mL |
Endocrinology |
| IgG sub 1 |
- |
Human Serum |
- |
- |
Immage |
750 - 20,000 mg/L |
Allergy & Immunology |
| IgG sub 2 |
- |
Human Serum |
- |
- |
Immage |
468 - 19,620 mg/L |
Allergy & Immunology |
| IgG sub 3 |
- |
Human Serum |
- |
- |
Immage |
156 - 25,000 mg/L |
Allergy & Immunology |
| IgG sub 4 |
- |
Human Serum |
- |
- |
Immage |
73.0 - 1500 mg/L |
Allergy & Immunology |
| IgG1 |
- |
Human Serum |
- |
- |
Immage |
200 - 3600 mg/dL |
Allergy & Immunology |
| IgG2 |
- |
Human Serum |
- |
- |
Spectrofotometric |
- |
Allergy & Immunology |
| IgG3 |
- |
Human Serum |
- |
- |
Spectrofotometric |
- |
Allergy & Immunology |
| IgG4 |
- |
Human Serum |
- |
- |
Spectrofotometric |
- |
Allergy & Immunology |
| IgG4 GP3 specific |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
200-50,000 µg/L |
Allergy & Immunology |
| IgG_2 |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.140 - [34.0 - 41.0] g/L |
Polyclonal & monoclonal gammopathies / Immunology |
| IgM |
- |
Human Serum |
- |
- |
Immage |
4.20 - 14,400 mg/dL |
Allergy & Immunology |
| IgM |
- |
Human Serum |
- |
- |
Spectrofotometric |
- |
Allergy & Immunology |
| IgM_2 |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.021 - [3.3 - 4.1] g/L |
Polyclonal & monoclonal gammopathies / Immunology |
| Indinavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.200 - 100 ng/ml |
- |
| Indocyanine green |
Human |
Plasma |
Heparin |
- |
HPLC |
0.250 - 10.0 µg/ml |
- |
| Inhibin |
- |
Human Serum |
- |
- |
Immage |
25.0 - 400 mg/dL |
Allergy & Immunology |
| Inhibin B |
- |
Human Plasma |
- |
- |
ELISA |
41.0 - 248 pg/mL |
Allergy & Immunology |
| Inhibin B |
- |
Human Plasma / Serum |
- |
- |
ELISA |
5.00 - 1000 pg/mL |
Allergy & Immunology |
| Inorganic Phosphorus |
- |
Serum, Li Heparin Plasma, Urine |
- |
- |
ADVIA 1800 |
0 - 6.44 mmol/L |
Bone Metabolism |
| Inosine |
- |
Human Serum |
- |
- |
ELISA |
10.0 - 1000 pg/mL |
Allergy & Immunology |
| Inosine |
- |
Human Urine |
- |
- |
LC/MS |
- |
CNS |
| Insulin |
- |
Human plasma |
- |
- |
LC/MS |
- |
CNS |
| Insulin |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
2 - 300 µIU/mL |
Diabetes |
| Insulin |
- |
Serum |
- |
- |
ADVIA Centaur |
0,5 - 300 mU/L |
Diabetes |
| Insulin (free) |
- |
Human Serum |
- |
- |
ELISA |
4.00 - 135 ulU/mL |
Metabolism |
| Insulin (total) |
- |
Human Plasma |
- |
- |
ELISA |
5.00 - 500 µIU/mL |
Metabolism |
| Insulin; zinc insulin (PK validation) |
- |
Human Serum |
- |
- |
ELISA |
10.0 - 500 µIU/mL |
Metabolism |
| Intact PTH |
- |
Serum, EDTA Plasma at +2°C/+8°C |
- |
- |
Immulite 2000 |
3 - 2500 pg/mL, 0.3 - 263 pmol/L |
Bone Metabolism |
| Inter CelluIar Adhesion Molecule -1 (ICAM-1) |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Inter CelluIar Adhesion Molecule -2 (ICAM-2) |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Inter CelluIar Adhesion Molecule -3 (ICAM-3) |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Interferon alpha |
- |
Human Plasma |
- |
- |
RIA |
- |
Allergy & Immunology |
| Interferon beta |
- |
Human Serum |
- |
- |
ELISA |
0.391 - 400 ng/mL |
Allergy & Immunology |
| Interferon gamma |
- |
Human Plasma / Serum |
- |
- |
ELISA |
250 - 10.000 pg/mL |
Allergy & Immunology |
| Interferon gamma |
- |
Human Plasma |
- |
- |
MSD |
2.44 - 10000 pg/mL |
Allergy & Immunology |
| Interferon gamma |
- |
Human Plasma, Medium Supernat. |
- |
- |
ELISA |
0.850 - 28.0 IU/mL |
Allergy & Immunology |
| Interferon gamma |
- |
Human Serum |
- |
- |
MSD |
0.610 - 2500 pg/mL |
Allergy & Immunology |
| Interleukin-1 (IL-1) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
3.90 - 250 pg/mL |
Allergy & Immunology |
| Interleukin-1-Alpha (IL-1a) |
- |
Human Plasma |
- |
- |
ELISA |
2.90 - 250 pg/mL |
Allergy & Immunology |
| Interleukin-1-Alpha (IL-1a) |
- |
Human Serum |
- |
- |
ELISA |
2.90 - 250 pg/mL |
Allergy & Immunology |
| Interleukin-1-Beta (IL-1beta) |
- |
Human Plasma |
- |
- |
MSD |
2.44 - 10000 pg/mL |
Allergy & Immunology |
| Interleukin-1-Beta (IL-1beta) |
- |
Human Serum |
- |
- |
MSD |
0.610 - 2500 pg/mL |
Allergy & Immunology |
| Interleukin-1-Ra (IL-1Ra) |
- |
Human Plasma, medium supernat. |
- |
- |
ELISA |
60.0 - 1700 pg/mL |
Allergy & Immunology |
| Interleukin-10 (IL-10) |
- |
Human Plasma, medium supernat. |
- |
- |
ELISA |
14.6 - 1600 pg/mL |
Allergy & Immunology |
| Interleukin-12 (IL-12) |
- |
Human Plasma |
- |
- |
ELISA |
7.80 - 500 pg/mL |
Allergy & Immunology |
| Interleukin-12 (IL-12) |
- |
Human Plasma |
- |
- |
MSD |
2.44 - 10000 pg/mL |
Allergy & Immunology |
| Interleukin-13 (IL-13) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
39.1 - 2500 pg/mL |
Allergy & Immunology |
| Interleukin-15 (IL-15) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
39.0 - 2500 pg/mL |
Allergy & Immunology |
| Interleukin-16 (IL-16) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
23.4 - 1500 pg/mL |
Allergy & Immunology |
| Interleukin-17 (IL-17) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
15.0 - 1000 pg/mL |
Allergy & Immunology |
| Interleukin-18 (IL-18) |
- |
Human Plasma |
- |
- |
ELISA |
78.1 - 5000 pg/mL |
Allergy & Immunology |
| Interleukin-2 (IL-2) |
- |
Human Plasma, medium supernat. |
- |
- |
ELISA |
2.50 - 25.0 mlU/mL |
Allergy & Immunology |
| Interleukin-2 (IL-2) |
- |
Human Plasma |
- |
- |
MSD |
2.44 - 10000 pg/mL |
Allergy & Immunology |
| Interleukin-2-Receptor, soluble (sIL-2R) |
- |
Human Serum |
- |
- |
ELISA |
240 - 7200 U/mL |
Allergy & Immunology |
| Interleukin-3 (IL-3) |
- |
Human serum |
- |
- |
ELISA |
1.95 - 500 ng/mL |
Allergy & Immunology |
| Interleukin-4 (IL-4) |
- |
Human Serum |
- |
- |
ELISA |
8.00 - 500 pg/mL |
Allergy & Immunology |
| Interleukin-5 (IL-5) |
- |
Human Serum |
- |
- |
ELISA |
8.00 - 500 pg/mL |
Allergy & Immunology |
| Interleukin-6 (IL-6) |
- |
Human Serum |
- |
- |
MSD |
0.610 - 2500 pg/mL |
Allergy & Immunology |
| Interleukin-6 (IL-6) |
- |
Human Plasma, medium supernat. |
- |
- |
ELISA Ultra Sensitive |
0.156 - 10.0 pg/mL |
Allergy & Immunology |
| Interleukin-6 (IL-6) |
- |
Human Plasma |
- |
- |
ELISA |
4.70 - 300 pg/mL |
Allergy & Immunology |
| Interleukin-6 (IL-6) |
- |
Human Plasma, medium Supernat. |
- |
- |
ELISA |
16.0 - 1690 pg/mL |
Allergy & Immunology |
| Interleukin-6 (IL-6) |
- |
Human Plasma |
- |
- |
MSD |
2.44 - 10000 pg/mL |
Allergy & Immunology |
| Interleukin-6R (IL-6R) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Interleukin-7 (IL-7) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
0.195 - 50.0 ng/mL |
Allergy & Immunology |
| Interleukin-8 (IL-8) |
- |
Human Plasma, medium supernat. |
- |
- |
ELISA |
7.80 - 790 pg/mL |
Allergy & Immunology |
| Interleukin-8 (IL-8) |
- |
Human Plasma |
- |
- |
MSD |
2.44 - 10000 pg/mL |
Allergy & Immunology |
| Intracellular cytokine expression |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| Irinotecan /SN-38 / SN-38 glucuronide |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
10.0 - 2500 / 1.00 - 250 / 1.00 - 250 ng/ml |
- |
| Iron total |
- |
Human Serum |
- |
- |
Spectrofotometric |
- |
Haematology |
| Iron transferrin Bound (sTfR) |
- |
Human Serum |
- |
- |
ELISA |
0.200 - 10.0 ug/mL |
Haematology |
| Iron_2 |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.34 - 179 mmol/L |
Anemia / Iron Metabolism |
| Isoniazid / pyrazinamide |
Human |
Plasma |
EDTA |
- |
HPLC |
0.0500 - 15.0 / 0.500 - 100 µg/ml |
- |
| Isotretion |
Rat |
Plasma |
Heparin |
- |
HPLC |
4.00 - 100000 dpm |
- |
| Kappa light Chain |
- |
Human Serum |
- |
- |
Immage |
11.1 - 26.400 mg/dL |
Haematology |
| Kappa light chain |
- |
Human Urine |
- |
- |
Immage |
1.85 - 26.400 mg/dL |
Haematology |
| Ketaconazole |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
10.0 - 10000 ng/ml |
- |
| L-Dopa |
- |
Human Plasma |
- |
- |
ELISA |
- |
CNS |
| L-Selectin |
- |
Human Plasma |
- |
- |
ELISA |
0.400 - 25,0 ng/mL |
Allergy & Immunology |
| L-Selectin |
- |
Human Plasma Platelet Poor |
- |
- |
ELISA |
0.400 - 25.0 ng/mL |
Allergy & Immunology |
| L-dopa / 3-O-methyldopa / carbidopa |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
20.0 - 3000 / 100 - 3000 / 10.0 - 1500 ng/ml |
- |
| LAC confirm |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| LAC screen |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| LH |
- |
Serum |
- |
- |
ADVIA Centaur |
0.07 - 200 mlU/mL |
Fertility |
| LH |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.1 - 200 mIU/mL |
Fertility |
| LTB4 |
- |
Human Plasma |
- |
- |
EIA |
11.7- 3000 pg/mL |
Immunology |
| Lactate |
- |
Fluoride Plasma, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA 1800 |
0 - 12.21 mmol/L |
Other Speciality Analytes |
| Lactate Dehydrogenase L-P |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
20 - 700 U/L |
Hepatic Diseases |
| Lactate Dehydrogenase P-L |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 1100 U/L |
Hepatic Diseases |
| Lambda light chain |
- |
Human Urine |
- |
- |
Immage |
5.00 - 38 9 mg/dL |
Haematology |
| Lambda light chain |
- |
Human Serum |
- |
- |
Immage |
30.0 - 25.200 mg/dL |
Haematology |
| Lamotrigine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
10.0 - 10000 ng/ml |
- |
| Lamotrigine, lamotrigine glucuronide |
Human |
Urine |
None |
- |
HPLC |
0.500 - 250 µg/ml |
- |
| Lamuvidine |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 1000 ng/ml |
- |
| Leptin |
- |
HumanSerum |
- |
- |
ELISA |
11.3 - 1000 ng/mL |
Metabolism |
| Leptin |
- |
Human Plasma / Serum |
- |
- |
ELISA |
15.6 - 1000 ng/mL |
Metabolism |
| Leucotriene |
- |
Human Urine |
- |
- |
ELISA |
7.80 - 1000 pg |
Respiratory |
| Leucotriene |
- |
Human Urine |
- |
- |
HPLC-RIA |
355 - 22750 pmol/L |
Respiratory |
| Leukocyten |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 3500 |
- |
General |
| Leukymia Inhibitor Factor (LIF-Hilda) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Oncology |
| Leuprolide |
- |
Human Plasma |
- |
- |
ELISA |
- |
Oncology |
| Lidocaine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
5.00 - 10000 ng/ml |
- |
| Lipase |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 700 U/L |
Pancreatic Disease |
| Lipoprotein (A) |
- |
Human Serum |
- |
- |
Immage |
2.00 - 640 mg/dL |
Metabolism |
| Lipoprotein (A1) |
- |
Human Serum |
- |
- |
Immage |
25.0 - 225 mg/dL |
Metabolism |
| Lithium |
- |
Serum |
- |
- |
ADVIA 1800 |
0.1 - 3.0 mmol.L |
Therapeutic Drug Monitoring |
| Lorazepam |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 50.0 ng/ml |
- |
| Lorazepam |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.100 - 50.0 ng/ml |
- |
| Losartan / E-3174 |
Human |
Serum |
None |
- |
HPLC |
10.0 - 1000 / 20.0 - 1000 ng/ml |
- |
| Losartan, losartan carboxylic acid |
Human |
Urine |
Heparin |
- |
HPLC |
10.0 - 1000 ng/ml |
- |
| Lovastatin / lovastatin acid |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 50.0 / 0.200 - 50.0 ng/ml |
- |
| Low concentration IGA |
- |
Human Serum |
- |
- |
Immage |
820 - 4530 mg/L |
Allergy & Immunology |
| Low concentration IGM |
- |
Human Serum |
- |
- |
Immage |
64.8 - 2160 mg/L |
Allergy & Immunology |
| Loxoprofen / trans-hydroxyloxoprofen |
Human |
Plasma |
EDTA |
- |
HPLC |
0.200 - 15.0 µg/ml |
- |
| Luteinizing Hormone (LH) |
- |
Human Serum |
- |
- |
ELISA |
2.90 - 161 mlU/mL |
Endocrinology |
| Luteinizing Hormone (LH) |
- |
Human Serum |
- |
- |
ELISA |
0.0624 - 49.3 mIU/mL |
Endocrinology |
| Luteinizing Hormone (LH) |
- |
Human Serum |
- |
- |
ELISA |
0.710 - 31.7 mIU/mL |
Endocrinology |
| Luteinizing Hormone (LH) |
- |
Human Serum |
- |
- |
RIA |
2.00 - 200 ng/mL |
Endocrinology |
| Luteinizing Hormone Releasing Hormone (LH-RH) |
- |
Human Plasma after extraction |
- |
- |
ELISA |
- |
Endocrinology |
| Macrophage Inflammatory Protein-1a (MIP-1a) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Macrophage Inflammatory Protein-1b (MIP-1b) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
15.6-1000 pg/mL |
Allergy & Immunology |
| Macrophage Inflammatory Protein-2 (MIP-2) |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Macrophage Inflammatory Protein-3 (MIP-3) |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Macrophage Inflammatory Protein-4 (MIP-4) |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Macrophage Inflammatory Protein-5 (MIP-5) |
- |
Human Serum |
- |
- |
ELISA |
- |
Allergy & Immunology |
| Magnesium |
- |
Serum, Li Heparin Plasma, Urine |
- |
- |
ADVIA 1800 |
0.294 - 2.1 mmol/L |
Other General Chemistry |
| Matrix metalloproteinase-1 |
- |
Human Plasma |
- |
- |
ELISA |
0.390 - 25.0 ng/mL |
Oncology |
| Mean Corpuscular Heamoglobin Concentration (MCHC) |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 4000 |
- |
General |
| Megestrol acetate |
Human |
Plasma |
Heparin |
- |
HPLC |
5.91 - 213 ng/ml |
- |
| Melanin concentrating hormone (MCH) |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 4000 |
- |
General |
| Melatonin |
- |
Human Plasma |
- |
- |
ELISA |
3.00 - 350 pg/mL |
Endocrinology |
| Melperone |
Human |
Plasma |
Heparin |
- |
HPLC |
2.00 - 120 ng/ml |
- |
| Metformin |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
15.0 - 8000 ng/ml |
- |
| Metformin |
Human |
Urine |
None |
- |
HPLC |
1.00 - 500 µg/ml |
- |
| Methadone (METHA) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 300, < 300 ng/mL |
Toxicology / Drugs of Abuse |
| Methadone Metabolite (METMTB) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 1000, < 1000 ng/mL |
Toxicology / Drugs of Abuse |
| Methotrexate |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 1000 ng/ml |
- |
| Methotrexate / 7-hydroxymethotrexate |
Human |
Plasma |
EDTA |
- |
HPLC |
2.00 - 500 / 5.00 - 750 ng/ml |
- |
| Methotrexate, 7-hydroxymethotrexate |
Rat |
Plasma |
Heparin |
- |
HPLC |
25.0 - 2500 ng/ml |
- |
| Methotrexate, 7-hydroxymethotrexate |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 500 ng/ml |
- |
| Methylphenidate |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Metoclopramide |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 100 ng/ml |
- |
| Metoprolol, a-hydroxy-metoprolol |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 500 ng/ml |
- |
| Micro Albumin A |
- |
Human Urine |
- |
- |
Immage |
0.200 - 864 mg/dL |
Nefrology |
| Microalbumin |
- |
Urine |
- |
- |
ADVIA 1800 |
6 - [195 - 220] mg/L |
Nephropathies |
| Microalbumin_2 |
- |
Urine |
- |
- |
ADVIA 1800 |
3 - [380 – 420] mg/L |
Nephropathies |
| Midazolam, 1-hydroxymidazolm, 4-hydroxymidazolam |
Human |
Plasma |
Heparin/EDTA |
- |
LC-MS/MS |
0.100 - 100 ng/ml |
- |
| Mitoxantrone |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 500 ng/ml |
- |
| Moclobemide |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 1000 ng/ml |
- |
| Monoamine oxidase (MAO) |
- |
Human Platelets |
- |
- |
ELISA |
- |
CNS |
| Monoamine oxidase B (MAO B) |
- |
Human platelets |
- |
- |
Enzymatic/LSC |
0.400 - 2.00 g/L |
CNS |
| Monocyote Chemoattractant Protein-1 (MCP-1) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
15.6 - 1,000 pg/mL |
Cardiovascular |
| Monocyote Chemoattractant Protein-3 (MCP-3) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
16.0 - 1,000 pg/mL |
Cardiovascular |
| Monocytes and granulocytes (CD14/CD16/CD45) |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunophenotyping |
| Monohydroxycarbamazepine |
Human |
Plasma |
Heparin |
- |
HPLC |
0.250 - 25.0 µg/ml |
- |
| Morphine |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 60.0 ng/ml |
- |
| Morphine / morphine-3-glucuronide / morphine-6-glucuronide |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.500 - 30.0 / 5.00 - 500 / 5.00 - 200 ng/ml |
- |
| Moxifloxacin |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
5.00 - 5000 ng/ml |
- |
| Myelo Peroxidase (MPO) |
- |
Human Sputum |
- |
- |
ELISA |
- |
Respiratory |
| Myoblobin |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
0.5 - 1000 ng/mL |
Cardiovascular |
| Myoglobin |
- |
Serum, Heparin Plasma |
- |
- |
ADVIA Centaur |
3.0 - 1000 ng/mL |
Cardiac |
| N-Telopeptide (procollogen N-term) |
- |
Human Serum |
- |
- |
ELISA |
- |
Metabolism |
| NT-pro-BNP |
- |
Heparine Plasma |
- |
- |
Immulite 2000 |
20 - 35000 pg/mL, 2.4 - 4130 pmol/L |
Cardiovascular |
| NTx |
- |
Human Urine |
- |
- |
ELISA |
1.00 - 3000 nM |
Bonemarkers |
| Naproxen |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 200 µg/ml |
- |
| Naproxen |
Human |
Plasma |
Heparin |
- |
HPLC |
2.00 - 100 µg/ml |
- |
| Naproxen, MX-1094 |
Human |
Plasma |
Oxalate |
- |
HPLC |
0.500 - 200 µg/ml |
- |
| Nefopam |
Human |
Plasma |
Heparin |
- |
HPLC |
4.00 - 200 ng/ml |
- |
| Nelfinavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
2.00 - 2000 ng/ml |
- |
| Nelfinavir, nelfinavir-M8 |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
1.00 - 100 ng/ml |
- |
| Neopterin |
- |
Human Serum |
- |
- |
ELISA |
1,.50 - 111 nmol/L |
Allergy & Immunology |
| Neurotensin (1-13) |
- |
Human Plasma |
- |
- |
RIA |
- |
CNS |
| Neurotensin (1-13) |
- |
Human Plasma after extraction |
- |
- |
ELISA |
- |
CNS |
| Nicotine Metabolite |
- |
Serum, Urine |
- |
- |
Immulite 2000 |
10 - 500 ng/mL |
Diverse |
| Nifedipine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.500 - 200000 ng/ml |
- |
| Nitrazepam |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 250 ng/ml |
- |
| Noradrenalin |
- |
Human Urine |
- |
- |
HPLC |
2.50 - 1000 ng/mL |
Cardiovascular |
| Noradrenaline |
Human |
Urine |
None |
- |
HPLC |
2.5 - 1000 ng/ml |
- |
| Norethindrone |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 – 50.0 ng/ml |
- |
| Norgestrel |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 50.0 ng/ml |
- |
| Nortriptyline |
Human |
Plasma |
EDTA |
- |
HPLC |
2.00 - 100 ng/ml |
- |
| Nt-proBNP |
- |
Human Plasma / Serum |
- |
- |
ELISA |
31.3 - 100 fmol/mL |
Cardiovascular |
| OM-MA (CA 125) |
- |
Serum |
- |
- |
Immulite 2000 |
1 - 500 U/mL |
Oncology |
| Omeprazole, 5-hydroxyomeprazole |
Human |
Plasma |
EDTA |
- |
HPLC |
10.0 - 1500 ng/ml |
- |
| Ondansetron |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Opiate (OP2000) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 2000, < 2000 ng/mL |
Toxicology / Drugs of Abuse |
| Opiate (OP300) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 300, < 300 ng/mL |
Toxicology / Drugs of Abuse |
| Osteapontin |
- |
Human Plasma |
- |
- |
ELISA |
0.310 - 20.0 ng/mL |
Bonemarkers |
| Osteocalcin |
- |
Human Plasma / Serum |
- |
- |
ELISA |
1.56 - 75.0 ng/mL |
Metabolism |
| Osteocalcin |
- |
Human Plasma |
- |
- |
ELISA |
2.00 - 90.0 ng/mL |
Metabolism |
| Oxazepam |
Human |
Plasma |
Heparin |
- |
HPLC |
1.00 - 20.0 ng/ml |
- |
| Oxyntomodulin |
- |
Human Plasma |
- |
- |
RIA |
0.150 - 30.0 ng/mL |
Metabolism |
| P-Selectin |
- |
Human Plasma |
- |
- |
ELISA |
- |
Allergy & Immunology |
| PAPP-A |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.03 - 10 mIU/mL |
Fertility |
| PIIINP |
- |
Human Serum |
- |
- |
RIA |
1.00 - 50.0 ug/mL |
Bonemarkers |
| PIIINP |
- |
Human Bronchoalveolar Lavage |
- |
- |
RIA |
1.00 - 50.0 ug/mL |
Bonemarkers |
| PINP |
- |
Human Bronchoalveolar Lavage |
- |
- |
RIA |
5.00 - 250 ug/mL |
Bonemarkers |
| PINP |
- |
Human Serum |
- |
- |
RIA |
5.00 - 250 ug/mL |
Bonemarkers |
| PSA |
- |
Serum |
- |
- |
ADVIA Centaur |
0.01 - 100 ng/mL |
Oncology |
| PSA |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.04 - 150 ng/mL |
Oncology |
| PSA third generation |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.003 - 20 ng/mL |
Oncology |
| Paclitaxel (taxol) |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
5.00 - 5000 ng/ml |
- |
| Pancreatic Amylase |
- |
Serum |
- |
- |
ADVIA 1800 |
0 - 1500 U/L |
Pancreatic Disease |
| Pancreatic polypeptide (PP) |
- |
Human Serum |
- |
- |
RIA |
6.24 - 200 pmol/L |
Metabolism |
| Pancreatic polypeptide (PP) |
- |
Human Serum |
- |
- |
ELISA |
12.3 - 3000 pg/mL |
Metabolism |
| Paracetamol |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
100 - 50000 ng/ml |
- |
| Paracetamol, -glucuronide, -sulphate |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 50.0 µg/ml |
- |
| Parathyroid Hormone Human (HPTH) |
- |
Human Serum |
- |
- |
ELISA |
15.0 - 1200 pg/mL |
Metabolism |
| Parathyroid Hormone Human (HPTH) |
- |
Human Plasma |
- |
- |
IRMA |
13.0 - 1500 pg/mL |
Metabolism |
| Parathyroid Hormone Human (HPTH) |
- |
Human Serum |
- |
- |
IRMA |
0.827 - 164 pmil/L |
Metabolism |
| Paroxetine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 50.0 ng/ml |
- |
| Pemetrexed |
Human |
Plasma |
Heparin |
- |
HPLC |
0.250 - 250 µg/ml |
- |
| PeptideYY (PYY) |
- |
Human Serum |
- |
- |
ELISA |
7.00 - 2600 pg/mL |
Metabolism |
| PeptideYY (PYY) |
- |
Human Serum |
- |
- |
RIA |
10.5 - 1350 pg/mL |
Metabolism |
| PeptideYY (PYY) |
- |
Human Plasma |
- |
- |
ELISA |
10.0 - 2000 pg/mL |
Metabolism |
| Phenabarbital |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
5 - 80 µg/mL, 22 - 347 µmol/L |
Antibiotics |
| Phencyclidine (PCP) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 25, < 25 ng/mL |
Toxicology / Drugs of Abuse |
| Phenobarbital |
Rat |
Plasma |
EDTA |
- |
HPLC |
0.250 - 50.0 µg/ml |
- |
| Phenobarbital |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
1.2 - [ 310.3 - 379.3] µmol/L |
Therapeutic Drug Monitoring |
| Phenobarbital |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
1.72 - 344.8 umol/L |
TDM |
| Phenobarbital |
- |
Serum |
- |
- |
ADVIA Centaur |
0.4 - 80 ug/mL |
TDM |
| Phenobarbital / p-hydroxyphenobarbital |
Human |
Plasma |
Heparin |
- |
HPLC |
0.250 - 50.0 / 0.250 - 25.0 µg/ml |
- |
| Phenobarbital / p-hydroxyphenobarbital |
Human |
Urine |
None |
- |
HPLC |
0.250 - 50.0 µg/ml |
- |
| Phenytoin |
- |
Serum, Plasma |
- |
- |
ADVIA 1800 |
3.13 - [142.56 - 174.24] µmol/L |
Therapeutic Drug Monitoring |
| Phenytoin |
- |
Serum |
- |
- |
ADVIA Centaur |
0.5 - 40 µg/mL |
TDM |
| Phenytoin |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
1.98 - 158.4 µmol/L |
TDM |
| Phenytoin |
Human |
Plasma |
Heparin |
- |
HPLC |
0.100 - 30.0 µg/ml |
- |
| Phenytoin |
Human |
Plasma Ultrafiltrate |
Heparin |
- |
HPLC |
25.0 - 2000 ng/ml |
- |
| Phenytoin |
Human |
Plasma |
Heparin |
- |
HPLC |
100 - 5000 ng/ml |
- |
| Phenytoine |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
2.5 - 40 µg/mL, 9.9 - 158 µmol/L |
Antibiotics |
| Phospholipids |
- |
Human Serum |
- |
- |
ELISA |
- |
Cardiovascular |
| Phospholipids |
- |
Human plasma |
- |
- |
ELISA |
- |
Cardiovascular |
| Pi-GST |
- |
Human Urine |
- |
- |
ELISA |
3.13 - 100 ug/L |
Hepatology |
| Pilocarpine, isopilocarpine, pilocarpic acid, isopilocarpic acid |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
2.00 - 50.0 ng/ml |
- |
| Pilocarpine, isopilocarpine, pilocarpic acid, isopilocarpic acid |
Human |
Urine |
None |
- |
LC-MS/MS |
40.0 - 1000 ng/ml |
- |
| Pimobendan, UD-CG-212 |
Human |
Plasma |
Heparin |
- |
HPLC |
0.100 - 50.0 ng/ml |
- |
| Pimozide |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
50.0 - 50000 ng/ml |
- |
| Pindolol |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| Pioglitazone |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
20.0 - 10000 nM |
- |
| Piroxicam |
Human |
Urine |
None |
- |
HPLC |
0.0500 - 5.00 µg/ml |
- |
| Piroxicam |
Human |
Plasma |
Heparin |
- |
HPLC |
0.100 - 10.0 µg/ml |
- |
| Plasmin Inhibitor (Alpha 2Antiplasmin) |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Plasminogen |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Plasminogen |
- |
Human EDTA/Citr Plasma |
- |
- |
Immage |
1.51 - 22.8 mg/dL |
Haematology |
| Plasminogen Activator Inhibitor-1 (PAI-1) |
- |
TPA/PAI depleted plasma |
- |
- |
ELISA |
2.00 - 50.0 ng/ml |
Coagulation |
| Plasminogen activator inhibitor 1 (PAI-1) |
- |
Human Plasma |
- |
- |
ELISA |
6.25 - 50.0 ng/mL |
Coagulation |
| Potassium ISE |
- |
Urine |
- |
- |
ADVIA 1800 |
3 - 300 mmol/L |
Electrolytes |
| Potassium ISE |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
1 - 10 mmol/L |
Electrolytes |
| Pramlintide |
- |
Human Plasma |
- |
- |
Immuno/Enzym |
- |
Allergy & Immunology |
| Prealbumin |
- |
Serum |
- |
- |
ADVIA 1800 |
50 - [700 - 800] mg/L |
Nutritional assessment |
| Prealbumin |
- |
Human Serum |
- |
- |
Immage |
7.00 - 60.0 mg/dL |
General |
| Prednisolone / cortisol |
Human |
Plasma |
Heparin |
- |
HPLC |
20.0 - 800 / 20.0 - 300 ng/ml |
- |
| Primidone |
Human |
Plasma |
Heparin |
- |
HPLC |
0.100 - 10.0 µg/ml |
- |
| Pro-ANP (1-30) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Cardiovascular |
| Pro-ANP (1-98) |
- |
Human Plasma |
- |
- |
ELISA |
- |
Cardiovascular |
| Pro-ANP (1-98) |
- |
Human Serum |
- |
- |
ELISA |
320 - 5000 fmol/mL |
Cardiovascular |
| ProClot |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Probenicid |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 200 ug/ml |
- |
| Progesteron |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
20.0 - 2000 pg/ml |
- |
| Progesterone |
- |
Human Serum |
- |
- |
ELISA |
0.200 - 40.0 ng/mL |
Endocrinology |
| Progesterone |
- |
Human Plasma |
- |
- |
LC-MS/MS |
20.0 - 2000 pg/mL |
Endocrinology |
| Progesterone |
- |
Human Urine |
- |
- |
RIA |
1.00 - 25.0 ng/mL |
Endocrinology |
| Progesterone |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.2 - 40 ng/mL, 0.6 - 127 nmol/L |
Fertility |
| Progesterone |
- |
Serum |
- |
- |
ADVIA Centaur |
0.21 - 60 ng/mL |
Fertility |
| Prolactin |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
0.5 - 150 ng/mL, 10.6 - 3180 mIU/L |
Fertility |
| Prolactin |
- |
Serum |
- |
- |
ADVIA Centaur |
0.3 - 200 ng/mL |
Fertility |
| Propafenone / norpropafenone / 5-hydroxypropafenone |
Human |
Plasma |
Heparin |
- |
HPLC |
50.0 - 1000 / 5.00 - 100 / 10.0 - 200 ng/ml |
- |
| Properdin Factor B |
- |
Human Serum |
- |
- |
Immage |
12.0 - 80.0 mg/dL |
Nefrology & Urology |
| Propoxyphene (PROPOX) |
- |
Urine |
- |
- |
ADVIA 1800 |
> 300 < 300 ng/mL |
Toxicology / Drugs of Abuse |
| Prostaglandin E |
- |
Human Serum |
- |
- |
HPLC |
- |
Allergy & Immunology |
| Prostaglandin E1 |
- |
Human Plasma / Urine |
- |
- |
ELISA |
5.00 - 5000 pg/mL |
Allergy & Immunology |
| Prostaglandin E2 |
- |
Human Plasma / Urine |
- |
- |
ELISA |
40.0 - 2500 pg/mL |
Allergy & Immunology |
| Prostate Specific Antigen (PSA) |
- |
Human Serum |
- |
- |
ELISA |
0.00 - 50.0 ng/mL |
Nefrology & Urology |
| Prostate Specific Antigen PSA (equimolar; free +ACT complexed) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
- |
Nefrology & Urology |
| Prostate Specific Antigen free (PSA-free) |
- |
Human Serum |
- |
- |
ELISA |
0.00 - 15.0 ng/mL |
Nefrology & Urology |
| Prostatic Acid Phosphatase |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
0.05 - 100 ng/mL |
Oncology |
| Protein C |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Protein Electroforese |
- |
Human Serum |
- |
- |
Paragon System |
- |
General |
| Protein S |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Protein Tyrosin Phosphatase-1B |
- |
Human Serum |
- |
- |
- |
- |
Metabolism |
| Prothrombin fragment 1+2 (F1+2) |
- |
Buffer |
- |
- |
ELISA |
- |
Coagulation |
| Prothrombine Time (PT) |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
General |
| Pseudoephedrine |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Pyridoxamine and Pyridoxine |
- |
Human Plasma |
- |
- |
ELISA |
1.00 - 100 nmol/L |
Metabolism |
| Pyridoxamine and Pyridoxine |
- |
Human Urine |
- |
- |
ELISA |
3.00 - 30.0 nM |
Metabolism |
| Pyrilinks |
- |
urine |
- |
- |
Immulite 2000 |
7 - 300 nM |
Bone Metabolism |
| Pyrilinks and Pyrilinks-D |
- |
Human Plasma / Serum |
- |
- |
ELISA |
0.750 - 12.0 nmol/L |
Metabolism |
| R-Hydrochlorothiazide |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 250 ng/ml |
- |
| RANTES |
- |
Human Plasma |
- |
- |
ELISA |
50.0 - 4500 pg/mL |
Infectious diseases |
| RICO |
- |
Cynomolhus Plasma |
- |
- |
Aggregation |
- |
Coagulation |
| RICO |
- |
Human Plasma |
- |
- |
Aggregation |
- |
Coagulation |
| Rabeprazole |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 1000 ng/ml |
- |
| Ranitidine |
Human |
Plasma |
EDTA |
- |
HPLC |
5.00 - 2000 ng/ml |
- |
| Ranitidine |
Human |
Plasma |
Heparin |
- |
HPLC |
2.00 - 200 ng/ml |
- |
| Rapid TSH |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.01 - 75 µIU/mL |
Thyroid |
| Renin (plasma renin activity) |
- |
Human Plasma |
- |
- |
Enzymatic/RIA |
0.300 - 50.0 ng/mL |
Cardiovascular |
| Renin (active antigen) |
- |
Human Plasma |
- |
- |
IRMA |
8.00 - 974 pg/mL |
Cardiovascular |
| Renin (active antigen) |
- |
Human Plasma |
- |
- |
RIA |
2.50 - 320 pg/mL |
Cardiovascular |
| Reticulocytes |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 4000 |
0.00 -1500 10^(/L |
General |
| Retinol Binding Protein |
- |
Human Serum |
- |
- |
Immage |
20.0 - 202 mg/L |
General |
| Retinol Binding Protein |
- |
Human Urine |
- |
- |
Immage |
0.440 - 35.0 mg/L |
General |
| Reverse T3 |
- |
Human Plasma / Serum |
- |
- |
RIA |
- |
Endocrinology |
| Rheumatoid Factor |
- |
Serum |
- |
- |
ADVIA 1800 |
3.5 - [90 - 110] IU/mL |
Autoimmune / Rheumatoid Disease |
| Rheumatoid Factor (RF) Igm |
- |
Human Serum |
- |
- |
ELISA |
+/- 25.0 - 75.0 IU/mL |
Allergy & Immunology |
| Rheumatoid factor |
- |
Human Plasma / Serum |
- |
- |
Immage |
20.0 - 28,800 IU/mL |
Allergy & Immunology |
| Rifabutin / 25-O-desacetylrifabutin |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 800 / 2.50 - 400 ng/ml |
- |
| Rifampicine / 25-desacetylrifampicine |
Human |
Plasma |
Heparin |
- |
HPLC |
0.200 - 20.0 / 0.100 - 5.00 µg/ml |
- |
| Rimantadine |
Human |
Plasma |
Na2-EDTA/NaF |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Risperidone, 9-hydroxyrisperidone |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.100 - 250 ng/ml |
- |
| Ristocetin |
- |
Human Plasma |
- |
- |
PAP-4 |
- |
General |
| Ritonavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
10.0 - 1000 ng/ml |
- |
| Ritonavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.200 - 100 ng/ml |
- |
| Ritonavir, Saquinavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
1.00 - 100 ng/ml |
- |
| Rosiglitazone |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
10.0 - 5000 nmol/l |
- |
| Rosiglitazone, N-desmethylrosiglitazone |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
1.00 - 1000 ng/ml |
- |
| Rubella G |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.2 - 500 IU/ mL |
TOR(CH) |
| Rubella IgG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
5-– 400 IU/mL |
Serology |
| Rubella IgM |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| Rubella M |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0 - 15.00 Index |
TOR(CH) |
| Russels Viper Venom |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| S- and R- Tofisopam |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
2.00 - 1000 ng/ml |
- |
| S- and R-Warfarin |
Human |
Plasma |
Heparin |
- |
HPLC |
50.0 - 4000 ng/ml |
- |
| S- and R-ketamine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
5.00 - 5000 ng/ml |
- |
| S- and R-mephenytoin |
Human |
Urine |
None |
- |
LC-MS/MS |
5.00 - 1000 ng/ml |
- |
| S- and R-verapamil / total norverapamil |
Human |
Plasma |
Heparin |
- |
HPLC |
2.50 - 250 / 5.00 - 500 ng/ml |
- |
| S-100B |
- |
Human Serum |
- |
- |
ELISA |
68.0 - 6300 pg/mL |
CNS |
| SHBG |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
2 - 180 nmol/L |
Fertility |
| STNFRP |
- |
Human Serum |
- |
- |
ELISA |
0.940 - 46.2 ng/mL |
Allergy & Immunology |
| Salbumatol |
Human |
Serum |
None |
- |
HPLC |
0.500 - 12.0 ng/ml |
- |
| Salicylate |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.1 - 7.2 mmol/L |
Drugs of Abuse / Toxicology |
| Salicylic acid |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 50.0 µg/ml |
- |
| Saquinavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
10.0 - 1000 ng/ml |
- |
| Saquinavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.200 - 100 ng/ml |
- |
| Saquinavir, ritonavir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
10.0 - 1000 ng/ml |
- |
| Scopolamine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
10.0 - 10000 pg/ml |
- |
| Scopolamine |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
10.0 - 10000 pg/ml |
- |
| Serotonin |
- |
Human Plasma |
- |
- |
RIA |
15.0 - 2500 ng/mL |
CNS |
| Serotonin |
- |
Human Serum |
- |
- |
ELISA |
20.0 - 2000 ng/mL |
CNS |
| Sertindole |
Rat |
Serum |
None |
- |
HPLC |
2.00 - 200 ng/ml |
- |
| Sertindole |
Dog |
Serum |
None |
- |
HPLC |
1.00 - 100 ng/ml |
- |
| Serum analyte A |
- |
Human Serum |
- |
- |
Immage |
4.50 - 67.5 mg/L |
General |
| Sex-Hormone Binding Globulin (SHBG) |
- |
Human Serum |
- |
- |
IRMA |
1.00 - 180 nmol/L |
Endocrinology |
| Sex-Hormone Binding Globulin (SHBG) |
- |
Human Serum |
- |
- |
ELISA |
3.50 - 31.0 nmol/L |
Endocrinology |
| Simvastatin, simvastatin acid |
Human |
Plasma |
EDTA / Heparin |
- |
LC-MS/MS |
0.050 - 50.0 ng/ml |
- |
| Sitagliptin |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.500 - 500 ng/ml |
- |
| Sodium ISE |
- |
Urine |
- |
- |
ADVIA 1800 |
10 - 400 mmol/L |
Electrolytes |
| Sodium ISE |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
100 - 200 mmol/L |
Electrolytes |
| Soluble transferrine receptor |
- |
Human Serum |
- |
- |
ELISA |
5.00 - 200 ng/mL |
Anemia / Iron Metabolism |
| SolubleTransferrin Receptor |
- |
Human Serum |
- |
- |
Immage |
0.700 - 8.50 mg/L |
General |
| Sorivudine |
Rat |
Plasma |
Heparin |
- |
HPLC |
50.0 - 10000 ng/ml |
- |
| Sotalol |
Human |
Plasma |
Heparin |
- |
HPLC |
0.100 - 10.0 µg/ml |
- |
| Specific IgE |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
0.1 - 100 kU/L |
Allergy & Immunology |
| Specific IgG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
2 - 200 mg/L |
Allergy & Immunology |
| Sulindac, -sulfide, -sulfone |
Human |
Plasma |
Heparin |
- |
HPLC |
0.100 - 5.00 µg/ml |
- |
| Sulphamethoxazole |
Human |
Plasma |
Heparin |
- |
HPLC |
2.50 - 100 µg/ml |
- |
| Sulpiride |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| T-cells (CD3/CD8/CD45/CD4) |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunophenotyping |
| T3 |
- |
Serum |
- |
- |
ADVIA Centaur |
0.1 - 8 ng/mL |
Thyroid |
| T3 |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
40 - 600 ng/dL, 0.61 - 9.2 nmol/L |
Thyroid |
| T3uptake |
- |
Serum |
- |
- |
Immulite 2000 |
10 - 70 % TU |
Thyroid |
| T4 |
- |
Serum |
- |
- |
ADVIA Centaur |
0.3 - 30 ug/dL |
Thyroid |
| TBG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
3.5 - 80 µg/mL, 65 - 1480 nmol/L |
Thyroid |
| THCG |
- |
Serum |
- |
- |
ADVIA Centaur |
2 - 1000 mlU/mL |
Fertility |
| THb *** %HbA1c |
- |
Whole blood |
- |
- |
HA8140 |
- |
Diabetes |
| TIBC |
- |
Serum |
- |
- |
ADVIA 1800 |
7.16 - 179 µmol/L |
Anemia / Iron Metabolism |
| TPA/PAI |
- |
Human Plasma |
- |
- |
ELISA |
0.00 - 40.0 ng/mL |
Coagulation |
| TRAP |
- |
Human Plasma |
- |
- |
PAP-4 |
- |
Coagulation |
| TSH |
- |
Serum |
- |
- |
ADVIA Centaur |
0.010 - 150 uIU/mL |
Thyroid |
| TSH |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.004 - 75 µIU/mL |
Thyroid |
| TSH-3 |
- |
Serum |
- |
- |
ADVIA Centaur |
0.004 - 150 µIU/mL |
Thyroid |
| TT4 |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
1 - 24 µg/dL, 13 - 309 nmol/L |
Thyroid |
| Tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 50.0 ng/ml |
- |
| Tartrate-resistant acid phosphatase 5b (TRACP 5b) |
- |
Human Plasma |
- |
- |
ELISA |
0.600 - 14.8 mU/mL |
Bonemarkers |
| Tenofovir |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
4.00 - 500 ng/ml |
- |
| Terbutaline |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 12.0 ng/ml |
- |
| Terfenadine carboxylic acid |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 300 ng/ml |
- |
| Testosterone |
- |
Human Serum |
- |
- |
RIA |
0.228 - 13.5 ng/mL |
Endocrinology |
| Testosterone |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
20 - 1600 ng/dL, 0.7 - 55 nmol/L |
Fertility |
| Testosterone |
- |
Serum |
- |
- |
ADVIA Centaur |
10 - 1500 ng/dL |
Fertility |
| Testosterone |
- |
Human Serum |
- |
- |
ELISA |
0.220 - 26.0 ng/mL |
Endocrinology |
| Testosterone (TT) |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Testosterone (free) |
- |
Human Serum |
- |
- |
RIA |
0.570 - 56.0 pg/mL |
Endocrinology |
| Testosterone (total) |
- |
Human Serum |
- |
- |
RIA |
0.700 - 55.0 nmol/L |
Endocrinology |
| Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9 carboxy-THC |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
1.00 - 500 ng/ml |
- |
| Theophyline |
- |
Serum |
- |
- |
Immulite 2000 |
1 - 60 µg/mL |
Antibiotics |
| Theophylline |
Human |
Plasma |
EDTA |
- |
HPLC |
0.500 - 20.0 µg/ml |
- |
| Theophylline |
Human |
Urine |
None |
- |
HPLC |
0.500 - 100 µg/ml |
- |
| Theophylline |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
2.4 - [219.8 - 268.6] µmol/L |
Therapeutic Drug Monitoring |
| Theophylline |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 20.0 µg/ml |
- |
| Theophylline 2 |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
2.8 - 222 µmol/L |
TDM |
| Theophylline 2 |
- |
Serum |
- |
- |
ADVIA Centaur |
0.5 - 40 µg/mL |
TDM |
| Thiobarbituric acid reactive substances (TBARS) |
- |
Human Plasma |
- |
- |
Chemical reaction with fluormetric detection |
0.250 - 10.0 nmol/mL |
Cardiovascular |
| Thrombin |
- |
Human Plasma |
- |
- |
PAP-4 |
- |
Coagulation |
| Thrombin AntiThrombin (TAT) |
- |
Human Plasma |
- |
- |
ELISA |
2.00 - 20.8 ng/mL |
Coagulation |
| Thrombin-anti-thrombin III complex (TAT) |
- |
Human Plasma |
- |
- |
ELISA |
2.00 - 20.8 ng/mL |
Coagulation |
| Thrombocyten (Platelets) |
- |
Human EDTA Blood |
- |
- |
Cell-Dyn 4000 |
0.00 - 2000 . 10^9/L |
General |
| Thromboxane B2 |
- |
Human Serum |
- |
- |
ELISA |
4.80 - 1000 pg/mL |
Coagulation |
| Thyroglobuline ( TG) |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
0.2 - 300 ng/mL |
Thyroid |
| Thyroid Stimulating Hormone (TSH) |
- |
Human Serum |
- |
- |
ELISA |
0.00 - 25.0 IU/mL |
Endocrinology |
| Thyroid Stimulating hormone (TSH) |
- |
Human Serum |
- |
- |
IRMA |
0.150 - 150 Miu/mL |
Endocrinology |
| Tianeptine |
Human |
Plasma |
Heparin |
- |
HPLC |
10.0 - 400 ng/ml |
- |
| Tiludronate |
Human |
Urine |
None |
- |
HPLC |
0.200 - 41.9 µg/ml |
- |
| Timolol |
Human |
Aqueous humor |
None |
- |
HPLC |
0.0500 - 1.50 µg/ml |
- |
| Tirofiban |
Human |
Plasma |
EDTA |
- |
LC-MS/MS |
0.500 - 250 ng/ml |
- |
| Tissue Inhibitors of Metalloproteinases 1 (TIMP-1) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
1.56 - 25.0 ng/mL |
Allergy & Immunology |
| Tissue Inhibitors of Metalloproteinases 2 (TIMP-2) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
8 .00 - 128 ng/mL |
Allergy & Immunology |
| Tissue Pathway Inhibitor Factor (TFPI) |
- |
Human Plasma |
- |
- |
ELISA |
- |
Hepatology |
| Tissue Plasmogen Activator (TPA) |
- |
Human Plasma |
- |
- |
ELISA |
0.00 - 30.0 ng/mL |
Coagulation |
| Tissue factor (TF) expression in neutrophils and monocytes |
- |
Human Whole Blood |
- |
- |
Flowcytometry |
- |
Immunology |
| TnI-Ultra |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.006 - 50 ng/mL |
Cardiac |
| Tobramycin |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.39 - 27.8 umol/L |
TDM |
| Tobramycin |
- |
Serum |
- |
- |
ADVIA Centaur |
0.18 - 13 ug/mL |
TDM |
| Tobramycin |
- |
Serum |
- |
- |
ADVIA 1800 |
0.66 - [24.82 - 26.54] µmol/L |
Therapeutic Drug Monitoring |
| Tobramycine |
- |
Human Plasma |
- |
- |
HPLC |
- |
General |
| Tobramycine |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
0.5 - 12 µg/mL, 1.1 - 26 µmol/L |
Antibiotics |
| Tolbutamide |
Human |
Plasma |
Heparin |
- |
HPLC |
0.500 - 100 µg/ml |
- |
| Tolbutamide / carboxytolbutamide / 4-hydroxytolbutamide |
Human |
Urine |
None |
- |
LC-MS/MS |
0.500 - 500 / 2.00 - 2000 / 0.750 - 750 umol/l |
- |
| Total IgE |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
1 - 2000 IU/ml |
Allergy & Immunology |
| Total IgE |
- |
Serum |
- |
- |
ADVIA Centaur |
1.5 - 3000 IU/mL |
Other |
| Total Protein |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0.02 - 0.12 g/L |
Hepatic Diseases |
| Total Protein (Urine) (UPRO) |
- |
Urine |
- |
- |
ADVIA 1800 |
10 - 140 mg/L |
Nephropathies |
| Total Protein (Urine) (UPRO) |
- |
Cerebral Spinal Fluid |
- |
- |
ADVIA 1800 |
80 - 320 mg/L |
Nephropathies |
| Total Protein (Urine) (UPRO_2) |
- |
Urine, Cerebral Spinal Fluid |
- |
- |
ADVIA 1800 |
0 - 1250 mg/L |
Nephropathies |
| Total anti HAV |
- |
Serum, Heparine Plasma, Na Citrate EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| Toxoplasma G |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.5 - 700 IU/ mL |
TOR(CH) |
| Toxoplasma IgG |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
5 - 250 IU/mL |
Serology |
| Toxoplasma IgM µ capture |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
- |
Serology |
| Toxoplasma M |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.10 - 40.00 Index |
TOR(CH) |
| Transaminasis |
- |
Human Serum |
- |
- |
Amperiometric gluthamade biosensor |
1.00 - 1000 umol/L |
Metabolism |
| Transferrin |
- |
Serum, Li Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA 1800 |
0.0001 - [4.4 - 5.5] g/L |
Anemia / Iron Metabolism |
| Transferrin |
- |
Human Serum |
- |
- |
Immage |
12.5 - 4500 mg/dL |
Haematology |
| Transferrin |
- |
Human Urine |
- |
- |
Immage |
0.200 - 864 mg/dL |
Haematology |
| Transforming Growth Factor 1 beta (TGF-beta 1) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
19.0 - 600 pg/mL |
Endocrinology |
| Transforming Growth Factor 2 beta (TGF-beta 2) |
- |
Human Plasma / Serum |
- |
- |
ELISA |
31.25 - 1000 pg/mL |
Endocrinology |
| Tretinoin |
Human |
Plasma |
Heparin |
- |
HPLC |
5.00 - 200 ng/ml |
- |
| Tretinoin (tretinoic acid) |
- |
Human Plasma |
- |
- |
HPLC |
5.00 - 200 ng/mL |
Gastrointestinal |
| Triazolam |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
0.100 - 50.0 ng/ml |
- |
| Triglyceride |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
0 - 6.105 mmol/L |
Cardiovascular Risk Assessment |
| Triiodothryonine |
- |
Human Serum |
- |
- |
ELISA |
0.00 - 10.0 ng/mL |
Endocrinology |
| Triiodothyronine-3 total (T3-total) |
- |
Human Serum |
- |
- |
ELISA |
- |
Endocrinology |
| Trimethoprim |
Human |
Plasma |
Heparin |
- |
HPLC |
0.0500 - 2.00 µg/ml |
- |
| Troponin I |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
0.2 - 180 ng/mL |
Cardiovascular |
| Tumor Necrosis Factor-RI soluble (sTNF-RI) |
- |
Human Plasma |
- |
- |
ELISA |
1.00 - 47.0 ng/mL |
Immunology |
| Tumor Necrosis Factor-RII soluble (sTNF-RII) |
- |
Human Plasma |
- |
- |
ELISA |
2.10 - 145 ng/mL |
Immunology |
| Tumor necrosis factor alpha (TNF-alpha) |
- |
Human Plasma, medium supernat. |
- |
- |
ELISA |
8.67 - 15.25 pg/mL |
Immunology |
| Tumor necrosis factor alpha (TNF-alpha) |
- |
Human Serum |
- |
- |
MSD |
0.610 - 2500 pg/mL |
Immunology |
| Tumor necrosis factor alpha (TNF-alpha) |
- |
Human Plasma |
- |
- |
MSD |
2.44 - 10000 pg/mL |
Immunology |
| Tup |
- |
Serum |
- |
- |
ADVIA Centaur |
NA |
Thyroid |
| Ubiquinone |
Human |
Plasma |
EDTA |
- |
HPLC |
50.0-2500 ng/ml |
- |
| Urea Nitrogen (BUN) |
- |
Serum, Li Heparin Plasma, Urine |
- |
- |
ADVIA 1800 |
1.75 - 52.5 mmol/L |
Other General Chemistry |
| Uric Acid |
- |
Serum, Li Heparin Plasma, Urine |
- |
- |
ADVIA 1800 |
0 - 1200 µmol/L |
Other General Chemistry |
| Urine Immunoglobulin G |
- |
Human Urine |
- |
- |
Immage |
0.300 - 6.00 mg/L |
Allergy & Immunology |
| Urine Transferin |
- |
Human Urine |
- |
- |
Immage |
0.200 - 864 mg/dL |
Haematology |
| VB12 |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
45 - 2000 pg/mL |
Anemia |
| Valproic Acid |
- |
Serum |
- |
- |
ADVIA Centaur |
1 - 150 µg/mL |
TDM |
| Valproic Acid |
- |
Serum, Li Heparin Plasma |
- |
- |
ADVIA 1800 |
30.4 - [935.6 - 1143.5] µmol/L |
Therapeutic Drug Monitoring |
| Valproic Acid |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
6.93 - 1039.5 µmol/L |
TDM |
| Valproinezuur |
- |
Serum, Heparine Plasma |
- |
- |
Immulite 2000 |
10 - 200 µg/mL, 69 - 1386 µmol/L |
Antibiotics |
| Vancomucyn |
- |
Serum, Heparine Plasma, EDTA Plasma |
- |
- |
Immulite 2000 |
3 - 100 µg/mL, 2 - 69 µmol/L |
Antibiotics |
| Vancomycin |
- |
Serum |
- |
- |
ADVIA Centaur |
0.67 - 90 µg/mL |
TDM |
| Vancomycin |
- |
Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0.46 - 62 µmol/L |
TDM |
| Vancomycin |
- |
Serum, Li Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA 1800 |
0.6 - [61.3 - 91.9] µmol/L |
Therapeutic Drug Monitoring |
| Vascular Cell Adhesion Molecule -1 (VCAM-1) |
- |
Human Serum |
- |
- |
ELISA |
1.17 - 75.0 ng/mL |
Allergy & Immunology |
| Vascular Endothelial Growth Factor |
- |
Human plasma |
- |
- |
ELISA |
15.6 - 1000 pg/mL |
Oncology |
| Vasoactive Intestinal Peptide (VIP) Alpco, kit |
- |
Human Serum |
- |
- |
RIA |
3.80 - 120 pmol/L |
Oncology |
| Verapamil |
Human |
Urine |
None |
- |
HPLC |
50.0 - 2500 ng/ml |
- |
| Verapamil, norverapamil |
Human |
Plasma |
Heparin |
- |
HPLC |
2.00 - 500 ng/ml |
- |
| Vitamin B12 |
- |
Serum, Heparine Plasma, EDTA Plasma* |
- |
- |
Immulite 2000 |
150 - 1000 pg/mL, 111 - 738 pmol/L |
Haematology |
| Von Willebrand Factor |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| Warfarin |
Human |
Plasma |
EDTA |
- |
HPLC |
5.00 - 1000 ng/ml |
- |
| Warfarin |
Human |
Plasma |
Heparin |
- |
HPLC |
50.0 - 3000 ng/ml |
- |
| Xanthine Oxidase |
- |
Human Urine |
- |
- |
Fluorometric |
> 200 nM |
Metabolism |
| Xanthine, Hypoxanthine, uric acid |
- |
Human Urine |
- |
- |
LC/MS |
- |
Metabolism |
| Xanthine, Hypoxanthine, uric acid |
- |
Human Urine |
- |
- |
Fluorometric |
> 0.100 mU/mL |
Metabolism |
| Zolmitriptan, 183C91 |
Human |
Plasma |
Heparin |
- |
LC-MS/MS |
50.0 - 15000 ng/ml |
- |
| a-MSH |
- |
Rat Plasma |
- |
- |
RIA |
5.00 - 300 pmol/L |
Endocrinology |
| aHAVM |
- |
Serum, Li/Na Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0,02 - 7,00 S/CO |
Infectious Disease |
| aHAVT |
- |
Serum, Li/Na Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
0 - 100 mIU/mL |
Infectious Disease |
| anti-TG |
- |
Serum, EDTA Plasma |
- |
- |
ADVIA Centaur |
10 - 500 U/mL |
Thyroid |
| anti-TPO |
- |
Serum, Heparin Plasma, EDTA Plasma |
- |
- |
ADVIA Centaur |
15 - 1300 U/mL |
Thyroid |
| c-Peptide |
- |
Serum |
- |
- |
ADVIA Centaur |
0,05 - 30 ng/mL |
Diabetes |
| c-Peptide |
- |
Urine (1/10 diluted) |
- |
- |
ADVIA Centaur |
0.05 - 30 ng/mL |
Diabetes |
| cAMP |
- |
Human Urine |
- |
- |
ELISA |
0.029 - 3.00 pmol/mL |
General |
| cAMP |
- |
Human Plasma |
- |
- |
RIA |
0.0506 - 90.3 nmol/L |
General |
| cGMP |
- |
Human Plasma / Serum |
- |
- |
ELISA |
0.16 - 100 pmol/mL |
General |
| canine TLI |
- |
Canine Serum |
- |
- |
Immulite 2000 |
1 - 50 ng/mL |
Canine |
| factor VIII |
- |
Human Citrate Plasma |
- |
- |
ACL9000 |
- |
Coagulation |
| iC3b |
- |
Human Plasma |
- |
- |
ELISA |
0.254 - 0627 ug/mL |
Allergy & Immunology |
| iPTH |
- |
Serum |
- |
- |
ADVIA Centaur |
2.5 - 1900 pg/mL |
Other |
| iPTH |
- |
EDTA plasma |
- |
- |
ADVIA Centaur |
0.265 - 201 pmol/L |
Other |
| sCD40L |
- |
Human Serum |
- |
- |
ELISA |
0.156 - 10.0 ng/mL |
Immunology |
| sCD62L |
- |
Human Serum |
- |
- |
ELISA |
0.100 - 64.2 ng/mL |
Immunology |
| sP Selectin |
- |
Human Plasma / Serum |
- |
- |
ELISA |
2.19 - 140 ng/mL |
Allergy & Immunology |
| tricyclische antidepressiva (TCA) |
- |
Serum |
- |
- |
ADVIA 1800 |
- |
Drug |